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ABSTRACT 
 
ERIN M. ROMES: Structural and biochemical analysis of dynein light chain-mediated 
homodimerization of cytoskeletal and nuclear pore proteins 
(Under the direction of Dr. Kevin C. Slep) 
 
The dynein light chain, Lc8/Dyn2, is a ubiquitous protein that acts as a scaffold, 
binding to many different target proteins in various cellular contexts. Here we describe S. 
cerevisiae Dyn2’s biophysical and structural interaction with the dynein intermediate chain, 
Pac11 at the dynein complex, and also Dyn2’s interaction with a nuclear pore protein, 
Nup159 in the cytoplasmic fibrils. We also demonstrate the structural and binding 
similarities between the Drosophila homolog, Lc8 binding to a centriole duplication protein, 
Ana2 and Dyn2’s interaction with Pac11 or Nup159. We obtained the first high-resolution 
crystal structure of Dyn2 bound to Nup159 peptides and subsequent structures of a 
homodimer of Dyn2 bound to two identical peptides of Pac11, and a homodimer of Lc8 
bound to two identical Ana2 peptides. We also characterized the thermodynamic binding 
profiles of Dyn2/Lc8 interacting with Pac11, Ana2, or Nup159 peptide binding sites and 
discovered that both Dyn2 and Lc8 are capable of two modes of binding peptides, 
endothermically or exothermically with KDs in the range of 0.5 to 20 µM. 
Results from these experiments highlight Dyn2/Lc8’s ability to act as a “dimerization 
machine” to possibly optimize Pac11, Ana2 and Nup159’s respective functions in the cell. 
Each of the Dyn2/Lc8 target proteins we have described here represents an essential 
component in their respective contexts. Pac11 is an essential scaffold that binds directly to 
  iii 
the dynein motor chain to modulate dynein velocity and processivity through various binding 
interactions, Ana2 is an essential centriole duplication protein that is responsible for 
nucleating a single procentriole so that a cell does not experience genomic instability as a 
result of improper chromosome distribution, and Nup159 is an essential protein in regulating 
mRNA export out of the nucleus through the nuclear pore. We provide evidence that 
Dyn2/Lc8 interacting in each of these processes affords the target protein the ability to 
optimize through dimerization. 
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CHAPTER 1 
INTRODUCTION 
 
The benefit of a ubiquitous scaffolding protein 
 In many cases separate proteins with the same or similar function evolved to act in 
specialized, and often highly regulated functions, such as separate kinases evolving to 
differentially distinguish protein targets for phosphorylation (Manning, 2002). There is a 
benefit to having one ubiquitous protein that can accomplish the same function in multiple 
cellular locations. Ubiquitous proteins do not use as much genetic space as having two 
separate proteins with the same function, and do not require as much regulatory support for 
proteins that are not subject to rigorous regulation scrutiny. All of these assumptions are 
contingent on the ubiquitous protein binding with the same mode in different cellular 
contexts or having some flexibility in binding. 
 In the case of scaffolding proteins, their function is to optimize the effectiveness of 
another protein by providing the opportunity to form a stable complex of two or more 
proteins so that binding avidity is increased. Additionally, scaffolding proteins often do not 
have a significant catalytic or biochemical function, but are often the subject of regulation 
due to their allosteric control of a functional complex (Good, 2011). 
The ability for a protein to interact with another copy of itself, or homodimerize, is 
necessary for proper function in many cases, and there are a few mechanisms for how the 
process of dimerization can occur. Dimerization often occurs through two specially formatted 
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α-helical domains that come together to form a coiled-coil. Coiled-coils require a specific 
heptad pattern in the amino acid sequence to stabilize the intra-, and inter-helix interactions 
(Zhou, 1992; Marsden, 2010). Some proteins contain the amino acid sequence pattern for a 
coiled-coil, but the coils are not long enough for specificity in an exclusive dimerization 
partner (Marsden, 2010). In cases such as this a scaffolding protein may provide enough 
specificity or stability for the coiled-coil to satisfactorily dimerize into a fully functional 
complex. Short coils have also been shown to convert from an α-helical to a β-strand form; a 
transition that is dependent on certain sequence cues, temperature, and peptide concentration 
(Aposolovic, 2010; Kammerer, 2006). This transition to β-strands may not be intentional (as 
in the case of amyloid formation in neurodegenerative diseases), but may provide flexibility 
as a gain-of-function interaction site for protein-mediated dimerization. 
Coiled-coil domains are sufficient for dimerization in some cases but specific patterns 
and longer amino acid chains are required to accomplish a dimer than a β-strand-β-strand 
interaction between a β-sheet and target protein β-strand (Su, 1994; Khakshoor, 2010). Su et 
al. determined that at least three heptad repeats (21 residues) are necessary for forming a 
stable two-stranded α-helical coiled-coil, and five heptad repeats (35 residues) are optimal 
for stabilizing length (Su, 1994). Some coiled-coils successfully form obligate dimers that 
only function properly when they are homodimerized as is the case for cytoskeleton motor 
proteins like cytoplasmic dynein and kinesins that are not processive as monomers 
(Peckham, 2011). 
We propose that the dynein light chain, Lc8/Dyn2, acts as a protein mediator to assist 
in dimerization, which in turn strengthens a weakly interacting dimer. We hypothesize 
protein dimerization through scaffolding mediators such as Lc8/Dyn2 may provide a 
  3 
platform for recruitment that might also allow for a point of regulation. Lc8/Dyn2’s 
mediation may afford less dedicated peptide sequence for a target binding protein that would 
otherwise rely on a coiled-coil for dimerization, and it may provide greater specificity for 
forming a homodimer than a coiled-coil of the same length. 
The objective of this thesis is to investigate structural and biochemical properties of 
Dyn2/Lc8 across diverse systems: the dynein motor, centrioles, and at the nuclear pore. 
These assays will be used to distill the common function of dimerization, as well as to 
highlight differences between Dyn2/Lc8’s interactions in these systems. The remainder of the 
introduction will present the three systems: 1) the microtubule cytoskeleton and its motor 
proteins, specifically dynein, 2) centriole structure and duplication, and 3) the structure and 
functional regulation of the nuclear pore complex. 
 
Lc8/Dyn2 is ubiquitously expressed, and a promiscuous protein 
Lc8/DYNLL/Dyn2 was originally characterized as a dynein light chain by King et al. 
due to its ability to co-purify and immunoprecipitate with cytoplasmic dynein (King, 1996). 
In fact, only about 30% of Lc8 in rat brain tissue is tightly associated with cytoplasmic 
dynein (King, 1996), so the other 70% is presumed to interact transiently with cytoplasmic 
dynein or in the cytosol. As with Dyn2, the higher dynein light chain orthologs, LC8 and 
DYNLL, bind partners outside of binding to the dynein intermediate chain and a dynein light 
intermediate chain, including the signaling molecules nNOS and Pak1, the apoptosis 
regulator Bim/Bmf, the myosin Va motor, and the mRNA localization protein Swallow 
(McCauley, 2007; Lightcap, 2008; Espindola, 2000; Benison, 2007).  
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Figure 1-1.    Dyn2/Lc8 binds to proteins with coiled-coil domains and a QT motif. 
A. Dyn2 binds to the S. cerevisiae dynein IC, Pac11, in two locations in the central portion of 
the protein. There is an N-terminal coiled-coil (all light green) and a C-terminal WD40 motif 
(all dark blue) with much of the remaining central structure predicted to be unstructured. The 
IC from rat also contains an N-terminal coiled-coil (resi. 1-70), and C-terminal WD repeat 
domain that is responsible for interaction with the heavy chain (McKenney, 2011; Ma, 1999). 
The N-terminal coiled-coil also corresponds to the dynactin, p150 binding site (resi. 1-123) 
(Vaughan, 1995). Mammalian IC also contain binding sites for the three types of dynein light 
chains: TcTex (resi. 138-148; purple), Lc8 (resi. 154-164; all orange), and Lc7/Roadblock 
(resi. 221-258; cyan) (Williams, 2007; Hall, 2010). There are two Lc8 binding sites within 
Ana2 that bookend the predicted coiled-coil region (resi. 195-230). Ana2 also contains two 
motifs that show unique sequence conservation among the STIL/Ana2/Sas-5 family called 
STAN (for STil/ANa2; dark green) and TIM (for truncated in microcephaly; tan). The final 
Dyn2 binding protein is Nup159, which shows an N-terminal WD40 motif, a central domain 
composed of FG repeats (typical of nuclear pore proteins; yellow), the Dynein light chain 
interacting domain (DID) contains five Dyn2 binding sites, and a C-terminal coiled-coil. B. 
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Sequence conservation of 45 Dyn2/Lc8 natural binding sites includes 41 from Rapali, 2011 
and the Pac11 and Ana2 binding sites. Sequence homology is colored according to the 
following amino acid code; RHK (blue), DE (red), FYW (green), AVILM (cyan), STNQ 
(black), and CGP (purple). 
 
Lc8/DYNLL/Dyn2 is also a promiscuous protein, involved in a diversity of protein 
interactions, in a number of different cellular contexts. The binding motifs for the light chain  
orthologs have been widely debated due to a number of sequence and binding mode 
exceptions (Rapali, 2011; Benison, 2007; Radnai, 2010). In S. cerevisiae, Dyn2 interacts with 
the dynein intermediate chain, Pac11, through tandem canonical 10-12 residue stretches, each 
containing a conserved QT motif (Fig. 1-1A) (Stuchell-Brereton, 2011). Many authors 
recognize the Lc8 binding motif has a high probability of a glutamine followed by a 
threonine/valine (Fig. 1-1B). There are, however a number of binding interactions where Lc8 
does not utilize this motif, such as p21 activated kinase 1 (Pak1) that contains a divergent 
serine then proline at the QT positions in the binding cleft (Lightcap, 2008). As of 2011, 
Rapali et al. reported 41 naturally occurring Lc8 binding motifs and most of the candidates 
also contained a separate dimerization domain, such as a coiled-coil (Rapali, 2011).  
Lc8 is capable of not only binding very diverse sequences, but it is also promiscuous 
in its binding mode, being able to utilize an exothermic or endothermic interaction in some 
cases. An exothermic binding mode is more commonplace for Lc8 and many other proteins 
because it indicates the formation of an extensive hydrogen-bonding network to overcome 
the entropic penalties. Lc8 is capable of binding endothermically, as in the case of nNOS 
(Nyarko, 2011), which likely indicates an entropic consolidation of hydrophobic surfaces and 
rearrangement of structural waters (Lumry, 1970; Eftink, 1983). A protein that is capable of 
binding a target motif through an exothermic motif, or an endothermic motif if necessary  
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Figure 1-2.    Structure of the Drosophila Lc8 in complex with the rat dynein IC shows 
an Lc8 dimer bound to two IC β-strands by two parallel β-sheets.  
A. A cartoon diagram of the Lc8-IC crystal structure shows a quaternary structure of Lc8 
dimerized in blue (chain A) and cyan (chain B) with two IC β-strands (residues 127-137) in 
dark (chain I) or light orange (chain L). There is a two-fold non-crystallographic rotational 
symmetry operator indicated in the z-axis between the two parallel β-sheets composed of five 
anti-parallel β-strands arranged β1-β4-β5-β2-β3’. Two α-helices from each monomer are 
arranged on top and bottom of the β-sheet sandwich that is peripherally bound to the IC 
through β-strand-β-strand interactions. B. The Lc8 dimer is turned 90° from A. and displayed 
in surface (gray) to show the zoomed in Lc8 binding pocket. IC (dark orange) binding 
residues show the wide binding pocket with few steric restrictions. The conserved Q135 and 
T136 are shown in green sticks to highlight their location near the end of the binding pocket. 
Figure made with pdb 2PG1 (Williams, 2007). 
 
allows a protein to be more flexible in the selected binding partners, and therefore more 
promiscuous. 
The regulation of Lc8 binding to a number of different partners occurs through a 
common mechanism of phosphorylation. Although this phosphorylation event has only been 
characterized as affecting Bim in the apoptosis pathway (Benison, 2009; Song, 2008), it is 
believed that phosphorylation is used to control Lc8’s ability to homodimerize, and therefore 
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mediate dimerization of target proteins. Previous work has shown that Lc8 is phosphorylated 
on Ser88 by p21-activated kinase (Pak1), although the specific kinase utilized is hotly 
debated (Song, 2008; Benison, 2009). Song et al. used an S88E phosphomimetic mutation to 
show that phosphorylation at this specific Ser88 dissociates the Lc8 dimer and abolishes 
Lc8’s ability to bind Bim (Song, 2008). 
Lc8 is composed of five β-strands that form an anti-parallel β-sheet with two α-
helices on one face (Fig. 1-2A). Lc8 homodimerizes and forms two parallel β-sheets that are 
sandwiched by the outer α-helices. One β-strand from each monomer completes the other 
monomer’s sheet and forms an anti-parallel β-strand interaction with the peptide that binds 
each monomer of Lc8 (Williams, 2007; Benison, 2007; Fan, 2001; Lightcap, 2008). It is 
therefore remarkable that Lc8 binds many different targets with different thermodynamic 
binding modes through the same binding cleft (Fig. 1-2B). 
While studies to date have biophysically characterized the Lc8/DYNLL, dynein light 
chains from Drosophila, rat, and human, molecular and biophysical details of the S. 
cerevisiae Dyn2 have remained outstanding. S. cerevisiae is a leading model system for 
biophysical, biochemical and genetic investigations of the nuclear pore complex and the 
cytoplasmic dynein motor complex.  
 
Lc8/DYNLL/Dyn2 interactions that are independent of the dynein complex illuminate a 
role as a dimerization machine 
Ubiquitous Lc8/DYNLL/Dyn2 has been structurally characterized as binding to a 
variety of targets independent of the dynein complex, such as neuronal Nitric Oxide Synthase 
(nNOS) (Chaudhury, 2008), Anastral spindle 2 (Ana2) (Wang, 2011), and a nuclear pore 
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protein (Nup159) (Stelter, 2007). There are even a few species of algae and flowering plants, 
such as Arabidopsis, that do not contain the dynein motor, but maintain the Lc8 homolog of 
the dynein light chain (Wickstead, 2007). Since only about 30% of Lc8 is tightly associated 
with cytoplasmic dynein (King, 1996) and some species do not contain other dynein complex 
proteins (Wickstead, 2007) it is probable Lc8 acts in a greater capacity than just as a 
scaffolding protein for the dynein motor complex.  
Evidence suggests that although other dynein associating factors can act independent 
of the dynein motor, such as another dynein light chain, TcTex, which remodels actin in 
neurite outgrowth (Chuang, 2005), many of their characterized functions indirectly affect the 
dynein motor. A number of proteins that have been shown to interact with Lc8/DYNLL are 
assumed to also interact with the dynein complex such as Bim (Puthalakath, 1999), Bmf 
(Day, 2004), and Gephyrin (Fuhrmann, 2002). We challenge these presumed interactions due 
to the lack of experiments exclusively showing the importance of the dynein motor in these 
interactions, and a few experiments showing the converse; that the dynein motor domain is 
not always included in associating factor functions.  
Although lc8∆/dyn2∆ does not have a strong phenotype, the deletion phenotypes of 
the proteins with which Lc8/Dyn2 interacts at the dynein motor complex have more severe 
deletion phenotypes (Pac11/DIC, STIL/Ana2, Nup159) (Stuchell-Brereton, 2011; Arquint, 
2012; Gorsch, 1995). pac11∆ in S. cerevisiae shows an inability to move the nucleus into the 
budding cell for proper cell division (Stuchell-Brereton, 2011). In 60% of STIL-depleted 
U2OS cells there were fewer than two centrioles, which supports that STIL/Ana2 is 
necessary for centriole duplication (Arquint, 2012). In the final example, Nup159 is an 
essential nuclear pore protein that when deleted or mutated in S. cerevisiae causes an 
  9 
accumulation of poly(A)+ RNA in the nucleus (Gorsch, 1995). These strong phenotypes in a 
variety of cellular processes draw attention to the importance of having functional binding 
interactions with Dyn2/Lc8 to ensure optimal processing in the aforementioned contexts. 
Given the diverse set of dynein light chain binding partners, both at the dynein 
complex and independent of the complex, it has been postulated that the dynein light chain 
functionally serves as a dimerization machine. This role correlates with the structures of 
higher Dyn2 orthologs that show dynein light chains complexed 2:2 with a variety of target 
peptides (Lightcap, 2008; Fan, 2001; Williams, 2007; Benison, 2008; Wang, 2003). In this 
study we aim to further our structural and biophysical understanding of Dyn2/Lc8 to derive a 
model for Dyn2’s role as a dimerization machine. 
 
Motors of the cytoskeleton 
The cytoskeleton is a network of proteins involved in cell organization, cell motility, 
internal cellular restructuring, and division. In eukaryotes there are two protein polymers that 
form polar cellular tracks for the various cellular functions; actin and tubulin. Like tubulin, 
actin is important in forming networks across the cytoplasm for signal transduction, cellular 
movement, and the movement of cargos intracellularly. Actin forms a single filament 
composed of two strands unlike tubulin’s unique, hollow tubes of typically 13 
protofilaments, called microtubules, which can then interact with a host of proteins for force 
generation and cargo transport. Actin contains a single class of motor proteins, called non-
muscle myosins that are able to move long distances along a single actin filament (Mehta, 
2001). There are two microtubule families of motor proteins that facilitate aspects of force 
generation and cargo transport. The kinesin family of proteins moves toward the plus end 
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direction of microtubules (with the exception of kinesin 14 family members) with many 
different types of kinesins thus delineated because they perform different tasks. The 
cytoplasmic dynein complex is a 1.2 MDa multifunctional motor protein that processes 
toward the minus end of microtubules with great importance in cell division, intracellular 
organelle transport and organization, and delivery of cargos across great distances within a 
cell (Nyarko, 2004). It is believed that dynein can accomplish such a great variety of tasks 
through the presentation of different scaffolding and regulatory proteins, called associating 
factors. Kinesin, however, has several different proteins to accomplish the various plus end 
directed functions that a single cytoplasmic dynein can accomplish with its associating 
factors. All three families of cytoskeletal motor proteins utilize ATP hydrolysis to generate 
force for their various functions, but myosin (such as the 119 kDa Dictyostelium Myosin-1B) 
and kinesin (such as the approximately 400 kDa Kinesin-1 complex) are much smaller and 
simpler than the comparative behemoth, dynein (1.2 MDa cytoplasmic complex) (Mooseker, 
1995; Kull, 2000; Nyarko, 2004). While much is known about kinesin and myosin family 
members, far less is known about structure and regulation of the dynein motor and dynein 
regulators. 
In vitro experiments of cytoplasmic dynein and kinesin have aided in our 
understanding of force generation and how these motors might work together to deliver 
cargos in vivo. Unlike kinesin’s regular 8 nm steps along a single microtubule protofilament, 
dynein primarily takes 8 nm steps, but it has the ability to take 4 to 24 nm steps and can 
switch protofilaments (Gennerich, 2007; Reck-Peterson, 2006). This flexibility in dynein’s 
step size is likely afforded by the inherent flexibility in dynein’s dimerization domain that 
acts like a lever arm, whereas kinesin’s linker domain is much shorter and not as flexible as a 
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lever arm (Vale, 2003). Under the load of a cargo, cytoplasmic dynein was additionally 
shown to have the ability to take steps backward (toward the plus end) in the presence of 
ATP, and even to take forward and backward steps in the absence of ATP hydrolysis 
(Gennerich, 2007). A WT stall force of 4.5 pN was measured for a single yeast motor 
(Gennerich, 2007), although yeast dynein has a slower measured velocity and lower 
dissociation rates as compared to other species of dynein (Cho, 2008). A number of studies 
aim to measure the cumulative possible velocity and capable force of multiple motors on a 
load (Gross, 2002; Hendricks, 2010; Leidel, 2012) to better understand how cargos might 
transport in vivo. There are two possible models for how dynein and kinesin might work 
tethered to the same cargo. Dynein and kinesin can either coordinate their movement, which 
would imply that one set of motors does not function during a given translation, or dynein 
and kinesin ensembles can have a tug-of-war, where the winner dictates the direction of 
movement (Bryantseva, 2012). Although in vivo evidence for either model is slim, it appears 
as though the two models work in concert, with some cargo-bound motors being more 
weakly bound to the microtubule than others (Bryantseva, 2012). Some of the dynein 
associating factors are also capable of binding kinesins, such as the p150 subunit of dynactin, 
so it is possible that the associating factors could provide mediation to coordinate dominance 
of motors. Many in vitro studies of dynein are done in the absence of regulatory associating 
factors that are also predicted to have a great impact on velocity, processivity, and possibly 
even force generation. 
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The structure of processive kinesin 
The kinesin motor is comprised of a heavy chain that homodimerizes to form a 
functional motor, which can process toward the plus end of microtubules with invariant 8 nm 
steps. The heavy chain contains an approximately 30 kDa globular motor domain that 
contains the highly conserved microtubule-binding site and catalytic site. Kinesins contain a 
coiled-coil, or stalk, for dimerization, and a tail that binds to the light chain scaffolding 
protein (Sack, 1999). The kinesin family can be divided into groups based on the 
organization of these three domains within the peptide, although the structural folds within 
the catalytic head domains are invariant (Endow, 2010). The tail has been less well 
characterized in kinesin, however, the kinesin light chain bound to the tail mediate binding to 
vesicles and organelles.  
In classic kinesin, three distinct light chains (KLC) have been reported, and are the 
result of alternative gene splicing. It is hypothesized that the three light chain isoforms 
provide functional differences for the specialized roles necessary for kinesin (Cyr, 1991). 
Recently, the crystal structures and specific binding interactions were solved to elucidate the 
differential binding properties of cargo selectivity for the KLC1 and KLC2 tetratricopeptide 
repeats binding a kinesin cargo, JIP, (Zhu, 2012). Although kinesin light chain’s mechanism 
for binding cargos has not been fully worked out, it is clear that the three isoforms utilize 
their tetratricopeptides to connect to cargo, unlike dynein’s many different scaffolding 
proteins binding with different modes. 
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Cytoplasmic dynein structure 
Cytoplasmic dynein in metazoans is composed of a catalytic homodimer of heavy 
chains (HC), and a number of non-catalytic subunits; two dynein intermediate chains (IC), 
three light intermediate chains (LIC), and three light chains (LC) (Fig. 1-3B). In fungi, such 
as S. cerevisiae, there are only three reported non-catalytic subunits that are canonical dynein 
components: the intermediate chain, Pac11, a light intermediate chain, Dyn3, and a light 
chain, Dyn2. Dynein also binds to other non-canonical associating factors such as the 
dynactin complex, lissencephaly 1 (LIS1)/Pac1, and the RZZ complex (Rod, Zwilch, Zw10) 
to regulate processivity and contribute to function. The absence of the dynactin or LIS1 
components by depletion phenotypically copies the loss of dynein function (Kardon, 2009), 
therefore these associating factors provide an essential component to dynein in vivo. 
Structure of the dynein heavy chain 
The heavy chain of cytoplasmic dynein is composed of an amino terminal (N-terminal) 
dimerization domain that is a predicted coiled-coil, and a carboxy terminal (C-terminal) 
motor domain (Fig. 1-3A). The N-terminal domain of dynein is predicted to contain the 
binding sites for the canonical associating proteins. In rat, cytoplasmic dynein binding sites 
for IC, LIC 1 and 2 binding to the HC were identified to have partial overlap but distinct 
binding regions using a series of co-immunoprecipitation experiments (Tynan, 2000). These 
experiments were found to corroborate mapping of the HC binding sites on Dictyostelium 
with a 72% homologous region between Dictyostelium and rat (Habura, 1999). It has also 
been shown through alignments that even some of the most divergent fungal species show 
high conservation in this particular region of the dynein HC, but the sequence by itself is not 
sufficient for HC dimerization (Habura, 1999). Although a great deal has recently been 
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discovered about the dynein motor structure and possible mechanism, there have not been 
significant studies on the role that the dimerization domain of the HC plays in coordinating 
dynein associating factors. 
The motor domain of dynein is composed of six ATP binding domains (although only 
four of six are actually capable of binding ATP) that are concatenated in a single polypeptide, 
thus making dynein a unique member of the ATPases Associated with various cellular 
Activities (AAA+) family. Recently, the crystallographic structure of the motor domain of 
the cytoplasmic dynein heavy chain in Dictyostelium was solved to 2.8 Å (Kon, 2012) and in 
S. cerevisiae to 3.3 Å resolution (Schmidt, 2012). Both of these structures are high enough 
resolution that peptide backbone and side chains can be more accurately determined than 
previous structures. These two structures allow for a better understanding of the organization 
of the dynein motor ring, as well as a more complete prediction of the motor mechanism. As 
previously mentioned, the first four AAA domains of the dynein motor contain sequence 
motifs necessary to bind and hydrolyze ATP, while the final two AAA domains are highly 
divergent and believed to provide more of a structural role (Cho, 2008). AAA1 is shown to 
be the main hydrolysis site because mutations at this site in the Walker A or Walker B motif 
abolish motility and decrease overall ATP turnover (Kon, 2004; Cho, 2008). The microtubule 
binding domain (MTBD) is an extension of AAA4 and contains the globular head that makes 
contact with the microtubule, as well as a coiled-coil stalk which shifts the registry in order 
to complete the ATP hydrolysis communication from the ring into the MTBD (Carter, 2010; 
Kon, 2011). Recent publications show the importance of the stalk of the MTBD, the AAA5 
strut contacting the stalk, and the linker domain that folds over the ring to communicate the 
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Figure 1-3.    Cartoon of the dynein holoenzyme shows how all of the canonical dynein 
associating factors interact at the N-terminus of the DHC.  
A. The domain arrangement of the dynein heavy chain contains an N-terminal dimerization 
domain with binding sites for LIC1 and LIC2, IC, and the HC (residue numbers for rat; 
Tynan, 2000). The motor domain contains six concatenated AAA domains with a 
microtubule binding domain (MTBD) between AAA4 and AAA5. B. A cartoon of the 
canonical dynein complex shows a ring of AAA domains with the MTBD protruding 
between AAA4 and AAA5 to bind the microtubule. The N-terminal linker folds over the ring 
in different conformations depending on the ATP hydrolysis state of the motor. The 
dimerization domain zoom shows a cartoon of how the dynein LCs (purple, orange, light 
blue), LIC (pink), and IC (dark blue) might bind along the shaft of the dimerization domain. 
Tan boxes point to locations where other dynein associating factors interact with the dynein 
holoenzyme to regulate dynein. This figure is based on Kardon, 2009. 
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ATP hydrolysis through the ring and into the MTBD (Carter, 2008; Carter, 2011; Kon, 2011; 
Kon, 2012; Schmidt, 2012).  
Structure of the canonical cytoplasmic dynein associating factors 
  Although a full length structure of a dynein intermediate chain has not been 
published, the domain structure and binding sites for other dynein associating factors have 
been determined using sequence analysis and biochemical assays (Stuchell-Brereton, 2011; 
Benison, 2007; Makokha, 2002; Williams, 2007; Hall, 2009). The very N-terminal portion of 
the IC contains a short, predicted coiled-coil (Makokha, 2002) and also contains the p150, 
dynactin subunit, binding site (Vaughan, 1995). The IC N-terminal domain follows an 
inherently disordered domain that gains structure upon binding to Lc8 (Nyarko, 2004), and 
contains binding sites for the other two LCs. The two light chain-binding sites for human 
TcTex and Lc8 were determined by x-ray crystallography to form a β-strand-β-strand 
interaction with the backbone of IC (Williams, 2007; Benison, 2007). The third LC that binds 
to the central domain of the IC, Lc7/Roadblock, interacts with two α-helices from the IC to 
form the binding site (Susalka, 2002; Hall, 2010). The final C-terminal domain of the IC 
contains seven WD-repeat motifs (Susalka, 2002;) predicted to form a β-propeller (Garcia-
Higuera, 1996), which then binds to the dynein heavy chain (Ma, 1999). 
 The LICs of dynein are isoforms of a single gene that undergoes differential 
phosphorylation and alternative splicing to form two cytoplasmic proteins (Hughes, 1995). 
Sequence analysis has shown that there appears to be no significant relationship between the 
LICs and the LCs, nor are there regions of predicted α-helical, or β-sheet secondary structure 
in the LICs (Hughes, 1995). The N-terminal domain of LIC contains a P-loop consensus 
sequence, which is used for binding nucleotides, and this putative ATP hydrolysis domain 
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also shares some homology with the ABC transporter family (Hughes, 1995). Although there 
is not very much known about the LIC’s function, its sequence homology with the ABC 
transporter family indicates LIC may bind and hydrolyze ATP (Mische, 2008). Mutations in 
the putative ATP-binding residues of C. elegans LIC (dli-1) have shown complete rescue of 
function, indicating that ATP hydrolysis is not necessary for LIC’s function (Yoder, 2001). 
In addition to Lc8/Dyn2 there are two more dynein light chains, Lc7/Roadblock and 
TcTex have similar secondary structural elements to Dyn2/Lc8, but Lc7’s secondary 
structure is a different fold, and they all have little sequence homology with each other. The 
light chains are thus named because they are less than 10 kDa on average, and are all non-
catalytic subunits. The Lc7/Roadblock structure in humans (Ilangovan, 2005), mouse (Song, 
2005), and Drosophila (Hall, 2010) were all shown to contain five β-strands that 
homodimerize to form one contiguous β-sheet with each monomer contributing two 
peripheral α-helices on either side of the β-sheet. The IC binds Lc7 with two amphipathic 
helices laid across the β-sheet and forms interactions throughout the molecule (Hall, 2010). 
The final category of dynein LC, TcTex, shares 1.6 Å RMSD strucutural homology with 
LC8, but is very divergent in sequence with almost no homology (Williams, 2005). TcTex 
binds non-overlapping sequences on target proteins in the same β-strand-β-strand interaction 
mode as Lc8 where each monomer binds a peptide along the midline β-sheet. TcTex, like 
Lc8, contains five β-strands and two α-helices that are arranged in the same fashion as Lc8 
except that the central β-strands and α-helices are much longer (Williams, 2005; Williams, 
2007). Although the three categories of dynein LC are structurally different and bind targets 
differently, they all share similar folds that incorporate a β-sheet with peripheral α-helices. 
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Function and regulation of the dynein holoenzyme 
Dynein’s role in vivo 
Cytoplasmic dynein has a variety of roles that are instrumental in cell movement, 
division, and intracellular transport of cargos. One of dynein’s primary roles in metazoans is 
in organelle transport such as movement of the Golgi apparatus (Corthesy-Theulaz, 1992; 
Holzbaur, 1994), lysosomes, and endosomes (Lin, 1992). For many of the larger organelles 
there are several dynein motors attached at any one time, which serves the role of 
overcoming the stall force for a single dynein motor, and to keep the organelle processively 
moving along the microtubule track (Bryantseva, 2012). The dynein complex has also been 
implicated in transport of vesicles, viruses, and packaged mRNA through LC mediation 
(Holzbaur, 1994; Vallee, 2004). It is not yet clear how dynein is specifically targeted to 
transport these particular cargos. 
Dynein is also responsible for positioning the chromatin in metaphase and plays a 
role in inactivating the spindle assembly checkpoint, which allows a cell to progress into 
anaphase (Bader, 2010). This role at kinetochores involves a number of associating proteins 
to sense and attach dynein to ingressing microtubules. Pools of dynein are also concentrated 
at the spindle poles and cell cortex during mitosis to assist in positioning the astral 
microtubules of the spindle (Busson, 1998). In S. cerevisiae, dynein’s sole responsibility is to 
position the mitotic spindle in the budding yeast so that the mother and daughter cells have 
proper DNA segregation (Eschel, 1993; Kahana, 1998; Moore, 2008). It is for this reason that 
many in vivo studies of cytoplasmic dynein utilize S. cerevisiae because dynein deletion cells 
are still viable (Geiser, 1997). The Cin8 pathway is synthetic with the PAC genes (perish in 
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the absence of Cin8) so the Kar9 and Cin8 pathways have some overlap with dynein and 
complete other functions typically associated with dynein in metazoans (Geiser, 1997).  
Intermolecular regulation of the dynein motor domain 
The dynein motor domain is internally regulated by AAA2-4 as well as by external 
adaptors that are crucial in adjusting the motor to its cellular function (Kardon, 2009). LIS1 
is the only known associating protein to bind directly to the dynein motor domain. LIS1 
binds directly between AAA3 and AAA4 to regulate communication between the catalytic 
motor and the microtubule-binding stalk, which prolongs dynein’s interaction with the MT 
and thereby increases processivity (Huang, 2012; McKenney, 2010). It appears as though this 
LIS1 binding interaction is most important during high bearing loads like transport of nuclei, 
movement of kinetochores, and during high tension in the cytoskeleton (McKenney, 2010). 
NudE is also important in the high load interactions and to recruit LIS1 and dynein to 
kinetochores (Stehman, 2007). NudE, however, interacts directly with the IC and LIC to 
abrogate dynein force production (McKenney, 2010). 
 Dynactin is a 1 MDa complex that has a role in modulating nearly every function of 
dynein’s behavior. In vitro experiments have shown that dynactin acts as a clutch for 
increasing dynein processivity (Kardon, 2009 PNAS). There are two microtubule-binding 
domains in the p150 subunits of dynactin that were thought to tether dynein to the 
microtubule to enhance processivity (Waterman-Storer, 1995). Mutant and deletion 
constructs of dynactin show that these microtubule-binding domains are dispensable and 
therefore not sufficient for increasing processivity (Kim, 2007). 
 Besides dynactin’s function in increasing dynein’s processivity, dynactin has also 
been reported to play a role in linking dynein to cargo (Holleran, 2001; Watson, 2005). 
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Interactions through the p150 subunit as well as the ARP1 scaffolding subunit both mediate 
interactions between dynein and cargo (Kardon, 2009). The ARP1 subunit directly interacts 
with a protein on the cytosolic surface of the Golgi, βIII spectrin, in the process of dynein-
dynactin mediated vesicle trafficking from the endoplasmic reticulum (Holleran, 2001). The 
p150 subunit not only binds to ARP1 and the dynein IC, but also to a number of microtubule 
plus end binding proteins such as EB1 and CLIP170 to target dynein to stably congress at 
microtubule plus ends (Hayashi, 2005; Hayashi, 2007). Dynein’s binding interactions with 
non-canonical proteins not only have the ability to modulate dynein’s behavior, but more 
importantly they alter dynein’s functionality in attachment and delivery of specific cargos 
during certain times. 
Through biochemical and structural studies we are gaining more insight as to how the 
dynein motor domain is organized and functions to promote motility in vitro, but there is still 
a great deal to learn about how this molecular machine selects and attaches to cargos for its 
in vivo functions. One hypothesis for dynein targeting cargos in fungi is that dynein is 
targeted to the plus ends of microtubules through the LIS1/NudE interaction or through the 
dynactin interaction to probe the cytoplasm for cargos as microtubules cycle through 
dynamic instability (Kardon, 2009). The mechanism for dynein targeting cargos in 
metazoans is less clear. 
  
Lc8/Ctp interacts with Ana2 on centrioles 
 Centriole duplication is a cell cycle-regulated process that plays a vital role in 
ensuring a cell is able to properly segregate its genetic material during mitosis (Fig. 1-4). 
Improperly formed or over-duplicated centrioles can result in a number of cellular 
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aberrations that amount to disease states such as primary microcephaly, male sterility, and 
cancer (Kitagawa, 2011; Nigg, 2009). The process and regulation of centriole duplication has 
recently become a popular topic because it is poorly understood and has possible clinical 
implications in drug therapies. 
Centriole structure 
 The structure of a centriole consists of a cylinder decorated by microtubule triplets 
with nine-fold radial symmetry; mature centrioles contain distal appendages that help 
assemble components to build the centrosome, the structure responsible for nucleating the 
bipolar mitotic spindle. The centrosome consists of a pair of centrioles: a mature (“mother” 
centriole), and a procentriole tethered by interconnecting fibers. A cloud of protein matrix, 
called pericentriolar material surrounds the centriole pair (Azimzadeh, 2011; Bornens, 2012). 
During centriole duplication, the nucleating procentriole forms perpendicular to the 
original centriole at the proximal end. The first structure for nucleating a daughter centriole is 
a central hub that forms like a wheel spoke with nine-fold symmetry accompanied by 
microtubule triplets around the periphery (Azimzadeh, 2012; Brito, 2012; Nigg, 2011). The 
central cartwheel, at the proximal end of a procentriole, remains within the daughter to form 
the scaffold for the remainder of the barrel structure (Brito, 2012; Kitagawa, 2011). The 
microtubule triplets on the daughter centriole are then elongated around a central lumen to a 
specified length that is dependent on cell type and species (Schmidt, 2009; Tang, 2009). 
Centriole biogenesis 
Centriole biogenesis can occur by either nucleating a procentriole (daughter) off of an 
existing centriole (mother) during duplication, or centrioles can form de novo (Brito, 2012; 
Rodrigues-Martins, 2007). Although these two processes are distinct, they utilize a conserved 
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Figure 1-4.    Centriole duplication involves seven essential proteins in higher 
eukaryotes.  
In the end of G1/early S phase of the cell cycle the duplication licensing protein, 
Plk4/Sak/Zyg1 is recruited by Cep152/Asl to begin formation of the cartwheel with 
Sas4/CPAP (brown). Sas6 and Cep135/Bld10 accumulate at formation of the cartwheel, and 
Sas-5/STIL/Ana2 interacts with Sas6 to initiate a single daughter centriole. Sas4/CPAP also 
acts to stabilize newly formed centriole microtubules in the elongation phase of duplication. 
In the final phase of centriole duplication Cep192/Spd2 stabilizes mitotic microtubules to 
nucleate the spindle. 
 
set of proteins to coordinate with the DNA replication cycle (Brito, 2012). The onset of 
centriole biogenesis coincides with late G1-phase when DNA is unwound to prime the 
replication machinery (Brito, 2012). There are three main phases of centriole duplication, 
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each of which contains opportunities for regulation: initiation/licensing, elongation, and 
capping/termination. The initial step of priming the centriole replication machinery is the 
onset of the licensing phase, which will commence assembling the daughter centriole 
cartwheel during the following S-phase of the cell. There are only a few proteins that are 
essential for centriole duplication including Cep152/Asl, Plk4/Sak/Zyg1, STIL/Sas-5/Ana2, 
Sas6, Cep135/Bld10, CPAP/Sas4, and Cep192/Spd2 (Vulprecht, 2012; Kitagawa, 2009). 
When any one of these seven proteins is deficient then centrioles duplicate irregularly or not 
at all. Although the cascade of proteins involved in the first steps appears to be hierarchical, 
the specific order of events and players is still poorly understood. The first known protein 
involved in the initial cascade is Cep152/Asl to recruit Plk4/SAK to centrioles and to act as a 
scaffold for CPAP/Sas4 to assemble or stabilize centriolar microtubules during the 
elongation phase (Carvalho, 2010; Stevens, 2010). Sas6 forms the initial cartwheel during 
initiation, and Sas-5/STIL1/Ana2 is a required Sas6 binding partner that is also required for 
controlling the number of procentrioles. The coiled-coil and C-terminal half of Ana2 is 
sufficient for binding to the N-terminal portion of Sas6 (Stevens, 2010). 
When centrosome duplication is disturbed there is an increased incidence of genomic 
instability due to compromised segregation of chromosomes. Therefore, the number of 
procentrioles generated on a mother centriole and the number of rounds of centriole 
duplication are crucial to fidelity of balanced centrosome number (Nigg, 2011). 
The second phase of assembly is the elongation of the daughter centriole from the 
cartwheel assembly, which occurs during S to G2 phase of the cell cycle. During this phase, 
initial microtubules are elongated using the γ-TuRC complex, and the other two microtubules 
within each triplet set utilize the stably nucleating microtubule as a template. There is an 
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unknown intrinsic property of the elongation machinery to make the daughter centriole a 
homogeneous length for the designated cell type and species, although post-translational 
modifications are suspected (Brito, 2012). The elongation machinery is also capable of 
distinguishing between daughter and mother centrioles with proteins like centrobin, so that 
only daughter centrioles elongate (Marthiens, 2012). Centrobin’s recruitment to α-tubulin 
core components is dependent on Sas6, so centrobin is capable of distinguishing between 
centriole types due to the formation of the inner cartwheel (Gudi, 2011). In the absence of 
centrobin, 58% of cells show daughter centrioles with stunted growth (Gudi, 2011). 
Therefore, centrobin acts in the elongation/stabilization phase that is directly dependent on 
the proper assembly of Sas6 during initiation. 
The final phase of centriole duplication is capping and disengagement of the newly 
matured centriole. A daughter centriole acquires distal and subdistal appendages that 
designate it as a fully matured centriole that is capable of replicating in future rounds of 
mitosis. During this final phase Cep192 targets AurA to mitotic centrosomes to assist in 
AurA oligomerization so that it can drive spindle microtubule assembly (Joukov, 2010). 
The role STIL/Sas-5/Ana2 plays in centriole licensing and elongation 
 STIL is a large, cytosolic protein in human cells that shares significant homology 
with Ana2 (from Drosophila) and Sas-5 (in C. elegans) and is also thought to be their 
functional ortholog (Arquint, 2012; Stevens, 2010). There is a coiled-coil domain in the 
central region of each of the STIL/Ana2 family members that was shown to be essential for 
Ana2 interacting with Sas6 (Stevens, 2010; Wang, 2011), but not Sas-5 interacting with Sas6 
(Stevens, 2010). Although STIL/Ana2/Sas-5 proteins show great variety in length, there are 
two areas of high sequence conservation between the 1300 amino acids in chordates and the 
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400 amino acid length arthropods (Arquint, 2012). Near the C-terminus there is an area of 
approximately 90 amino acids called the STAN motif (for STil/Ana2) that shows 31% 
identity between Drosophila Ana2 and zebrafish STIL (Stevens, 2010). The most divergent 
member of the STAN motif is in the C. elegans Sas-5 sharing only 12% identity with the 
zebrafish STIL. At the very C-terminus there is a second motif that shows high sequence 
similarity, called TIM (Truncated In Microcephaly) (Arquint, 2012). This area of sequence 
was named because truncation of the very C-terminus of human STIL results in fewer 
asymmetrically divided progenitor neurons due to abnormal centriole function, thus resulting 
in microcephaly (Kumar, 2009). 
STIL, Ana2, and Sas-5 were shown to be functional orthologs because they all 
function in licensing only one daughter centriole to nucleate from a mother and share 
sequence motifs (Arquint, 2012), as a result they are one of the seven essential proteins in 
centriole duplication (Delattre, 2004). This mechanism for licensing a single daughter 
centriole is still unclear, but depletion of endogenous STIL causes 60% of U2OS cells to 
contain fewer than two centrioles (Arquint, 2012). STIL and Ana2 studies also showed that 
overexpression of STIL/Ana2 results in multiple daughter centrioles nucleating off a single 
mother centriole that results in genomic instability (Arquint, 2012; Stevens, 2010). These 
experiments demonstrate the importance for regulating STIL/Ana2/Sas-5 for gaining a single 
daughter centriole on all duplicating mother centrioles. The protein responsible for this 
regulation is a serine/threonine phosphatase called PP2A (Kitagawa, 2011). The majority of 
Sas-5 is in the phosphorylated form during steady state in C. elegans. Upon 
dephosphorylation by PP2A, Sas-5 is targeted to centrioles for a duplication event (Kitagawa, 
2011).  
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Dynein Lc8 from Drosophila interacts with Ana2 to assist in mitotic spindle orientation 
In addition to centriole duplication, Ana2 forms a complex with a number of astral 
microtubule binding proteins to orient the mitotic spindle for asymmetric division of 
Drosophila neuroblasts (Wang, 2011). Ana2 mutant neuroblast spindle poles were 
disengaged from centrosomes, which resulted in disorganized spindles and misoriented 
assemblies (Wang, 2011). Severe spindle misorientation in asymmetrically dividing cells like 
neuroblast progenitors can result in hyperproliferation and tumorigenesis (Caussinus, 2005). 
The dynein light chain from Drosophila, Lc8 was shown to interact with the central 
domain of Ana2 which contains a coiled-coil; co-localizing to the distal ends of centrioles 
(Wang, 2011). Lc8 mutants on their own were also shown to have a similar, although less 
severe, misoriented spindle phenotype as the Ana2 mutants (Wang, 2011).  
We hypothesize that the domain containing the coiled-coil within Ana2 has 
demonstrated importance for binding interactions with Lc8 and Sas6, and this validates 
Ana2’s need to dimerize. Although Lc8 mutants were only shown to produce a moderate 
number of cells with a severe phenotype, we hypothesize this phenotype may be more severe 
when Ana2 is incapable of dimerizing through its coiled-coil domain. We plan to test the 
importance of Lc8’s role in mediating Ana2 dimerization through Ana2 mutational studies in 
our future work. 
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Figure 1-5.    A cartoon diagram of the Nuclear Pore Complex illustrates how exported 
mRNA interacts with the cytoplasmic fibrils.  
The nuclear pore is composed of a ring of transmembrane proteins with a nuclear basket 
structure and cytoplasmic fibrils that have both been identified as structurally and 
functionally important in nuclear pore transport. The central core of the pore contains a web 
of proteins with FG repeats, which can move aside to permit translocation. Dbp5 interacts 
with the mRNA export machinery and the cytoplasmic fibril as the final step in nuclear pore 
exit.  
Dyn2 interacts with Nup159 on the cytoplasmic side of the nuclear pore 
The S. cerevisiae Nuclear Pore Complex (NPC) is a 66 MDa structure composed of 
approximately 30 different proteins that embed in the nuclear envelope and facilitate 
transport across this barrier (Fig. 1-5) (Rout, 2000). NPC proteins are highly conserved in 
function and sequence across eukaryotes and carry out biologically conserved functions: 
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mRNA export into the cytoplasm and gated transport of specific proteins into and out of the 
nucleus.  
The proteins that make up this highly coordinated and complex structure form an 
eight-fold symmetrical pore from a limited number of structural folds (Maul, 1971). The 
types of domains in the nuclear pore proteins, or nucleoporins (Nups), are primarily α-
solenoids, β-propellers, Phe-Gly (FG) rich repeats, coiled-coil domains, and transmembrane 
domains (Schwartz, 2005; Alber, 2007). Transmembrane domains traverse the double 
nuclear envelope membrane and underlie the NPC core topology and biogenesis (Gerace, 
1988; Tcheperegine, 1999). FG repeats are primarily concentrated in the core interior where 
they function as a physical or entropic barrier to entering proteins while reversibly binding 
nuclear transport receptors and selectively allowing their passage (Rout, 2000; Ribbeck, 
2001). On either side of the core, asymmetrically distributed elements are positioned to 
facilitate asymmetric, unidirectional transport. The nucleoplasmic side of the NPC contains 
proteins tethered into a basket-like structure that protrudes 95 nm into the nucleus, potentially 
serving as a molecular checkpoint for pre-mRNA before it exits the nucleus (Fahrenkrog, 
1998; Galy, 2004). On the cytoplasmic surface, NPC fibrils stretch 50 nm into the cytoplasm 
(Fahrenkrog, 1998). Cytoplasmic fibrils are primarily composed of nucleoporins from the 
Nup82 complex that bind translation initiation factors and mRNA export machinery (Allen, 
2002). The Nup82 complex consists of Nup82, Nup159 and Nsp1 that work with Nup116, 
Nup42, Gle1, and Nup100, to mediate mRNA export in concert with the mRNA nuclear 
export receptor Mex67 and the DEAD box RNA helicase Dbp5 (Alber, 2007; Stelter, 2007; 
Bailer, 2000; Hodge, 2011). 
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 Nup159 is a prime component of the Nup82 complex and plays a directed role in 
coordinating nucleoporins involved in mRNA export rather than protein trafficking between 
the cytoplasm and nucleus (Del Priore, 1997). Nup159 has an extended multi-component 
architecture that facilitates its roles in mRNA export, as well as filament localization in the 
NPC structure (Del Priore, 1997; Weirich, 2004; Gorsch, 1995; Schmitt, 1999). Nup159’s N-
terminal domain constitutes a seven-bladed β-propeller that extends into the cytoplasm and 
mediates Dbp5 binding (Miller, 2004). Deletion of Nup159’s N-terminal domain results in a 
temperature-sensitive phenotype, lethal at 37°C and hallmarked by Dbp5 mislocalization and 
constitutive mRNA export defects at 23°C (Del Priore, 1997; Gorsch, 1995). Nup159’s 
central 700 amino acids form an FG-rich repeat domain. C-terminal to the FG-rich repeats is 
a 100 amino acid region termed the dynein light chain interacting domain (DID) that uses a 
pentameric array of dynein light chain binding motifs to bind the yeast dynein light chain 
Dyn2 (Stelter, 2007). C-terminal to the DID, Nup159 contains a predicted helical region 
(Kraemer, 1995) that is essential for Nup159’s stability and localization on the NPC, and has 
recently been shown to form a heterotrimeric structure with Nup82 and Nup116 (Del Priore, 
1997; Gorsch, 1995; Yoshida, 2011). Higher-order oligomerization of the Nup82 complex 
requires both the Nup159 DID region as well as Dyn2 (Stelter, 2007). The functional role of 
a dynein light chain at the nuclear pore is independent of its role in the cytoplasmic dynein 
microtubule motor complex (Stelter, 2007).  
 
Research Objectives 
This dissertation describes work done to further our understanding of how Lc8/Dyn2 
interacts both with the canonical dynein proteins as well as in other cellular functions.  
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 We set out to characterize the S. cerevisiae dynein light chain, Dyn2 interacting in the 
protein complex for which it was named, the dynein complex. It was previously established 
that Dyn2 interacts directly with the intermediate chain, Pac11 (also S. cerevisiae) but the 
Dyn2 binding sites on Pac11 were not structurally or biophysically characterized. We solved 
the co-complex of Dyn2 binding to a peptide of one of the two reputed Pac11 binding sites as 
well as biophysically characterized the binding affinity of Dyn2 for Pac11 at this site. We 
hypothesize that Dyn2-mediated dimerization of Pac11 modulates Pac11’s function in 
attaching to the dynein heavy chain or directly modulating the processivity of the dynein 
complex. We designed two mutations in Dyn2 to determine whether Dyn2-mediated 
dimerization of Pac11 is necessary for affecting Pac11’s ability to bind the dynein heavy 
chain. One double point mutant knocks out Dyn2’s ability to bind Pac11 but maintains a 
Dyn2 homodimer, and a single point mutation that ablates Dyn2’s ability to homodimerize 
and also the ability to bind Pac11. Our collaborators will assess the processivity of the dynein 
complex with in vitro tracking assays utilizing these Dyn2 mutants in future work. 
 In our initial investigations of Lc8 interacting with the centriole duplication protein, 
Ana2 we plan to focus on establishing the structural and biochemical binding parameters for 
this Lc8 interaction. We determined two potential Lc8 binding sites on Ana2 through 
sequence analysis and found that both Ana2 peptides bind Lc8 with measureable affinity. 
Although one of the Ana2 peptide binding sites does not follow the canonical Lc8/Dyn2 
recognition sequence, it was still able to have affinity consistent with previously measured 
Lc8 affinities, but weaker than the canonical motif. We hypothesize that this non-canonical 
binding motif utilizes a different set of hydrogen bonds for binding, but we will test this 
hypothesis in our future work. To date we have been unable to obtain a crystal structure of 
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Lc8 in complex with the non-canonical Ana2 peptide-binding site, and we will continue to 
improve the refinement of the crystals for solving this structure. Lastly, we aim to determine 
whether Ana2’s interaction with Lc8 is necessary for dimerization, and whether dimerization 
of Ana2 is required for Ana2 to function properly in centriole duplication and in orienting the 
mitotic spindle. These in vivo experiments will be part of our future experimentation to 
determine the importance of the Lc8-Ana2 complex. 
For studying how the dynein light chain interacts at the nuclear pore I chose to focus 
on the S. cerevisiae LC homolog, Dyn2. The budding yeast is a highly utilized model 
organism for studying dynein, and Dyn2 had not been structurally characterized. This body 
of work describes the first structure of the S. cerevisiae Dyn2, bound to a Nup159 peptide 
where only biochemical interactions have been shown with Dyn2. We show that Nup159 is 
the first known example of a single macromolecule that is capable of binding to Lc8/Dyn2 
with one endothermic profile and another site with exothermic favorability. We hypothesized 
that even though there was only 50% sequence identity between S. cerevisiae Dyn2 and 
Drosophila Lc8 there would be a similar structural organization and mechanism for binding 
peptides.  
We set out to establish the binding parameters for strength of interaction between 
Dyn2/Lc8 and target peptides and determined Dyn2/Lc8’s relative affinity for Pac11, Ana2 
at two binding sites, and Nup159 at two binding sites. Importantly, we provide evidence here 
that Dyn2 acts in more capacities than just as a scaffolding protein for Pac11, Ana2 and 
Nup159. Here we find that Dyn2/Lc8 acts to mediate/stabilize dimerization as a possible 
point of regulation for three particular targets at the dynein complex, via its centriole 
interaction, and at the nuclear pore.  
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CHAPTER 2 
 
THE STRUCTURE OF A YEAST DYNEIN DYN2-PAC11 COMPLEX AND EFFECT 
ON SINGLE MOLECULE DYNEIN MOTOR ACTIVITY 
 
Preface 
 This work is a manuscript in preparation. Lu Rao (Laboratory of Arne Gennerich at 
Albert Einstein College of Medicine) performed the expression and preparation of rhodamine 
labeled Dyn2 and Pac11 as well as the single molecule motility assays, which are not 
presented here but will be part of the final manuscript. Ashutosh Tripathy assisted me with 
the size exclusion chromatography-multi-angle light scattering experiments as well as the 
isothermal microtitration calorimetry. I performed the remaining experiments and protein 
preparation. My advisor, Kevin Slep, and I designed the project and experiments I 
performed. Kevin Slep, Arne Gennerich, Lu Rao, and I wrote and edited the final manuscript. 
 Romes, EM, Rao, L, Tripathy, A, Slep, K, and Gennerich, A. (manuscript in 
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Summary 
 The dynein complex is a 1.2 MDa complex that consists of a motor on the heavy 
chain and a dimerization domain that binds to dynein associating proteins (Nyarko, 2004). 
The dynein associating proteins modulate dynein’s functional efficiency on the microtubule 
tracks as well as function as scaffolds with which to attach dynein cargos (Kardon, 2009; 
Rapali, 2011; Williams, 2007). The dynein intermediate chain, Pac11 is believed to function 
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in both of these capacities and binds directly to a dynein light chain, Dyn2 to assist and/or 
stabilize dimerization of Pac11 at two binding sites (Stuchell-Brereton, 2011). We 
determined the binding affinity of Dyn2 for the Pac11 second binding site (pep2) to have a 
KD of 620 nM, which is the tightest Dyn2 binding interaction characterized to date. We also 
present the 1.90 Å resolution crystal structure of full length Dyn2 in complex with a peptide 
from the second of two Pac11 binding sites (pep2). Based on this crystal structure we 
designed a double point mutant (F76K/Y78E) that ablates Dyn2’s ability to bind to the Pac11 
pep2, but maintains Dyn2’s ability to dimerize. We additionally confirmed that a single point 
mutant discussed in previous work on the Drosophila homolog, Lc8 (H55K), ablates Dyn2 
dimerization and consequently also the ability of Dyn2 to bind to the Pac11 pep2. These 
point mutation tools will likely prove useful in dissecting whether Dyn2’s role in 
dimerization is necessary for the function of Pac11 interacting with the dynein heavy chain or 
with cargo. Future experiments will aim to determine the role that Dyn2 plays in modifying 
dynein processivity and localization, as well as whether Dyn2’s function as a dimerization 
machine affects Pac11’s ability to modulate dynein processivity. 
 
Experimental Procedures 
Cloning, Expression, and Purification of Full Length Dyn2 from S. cerevisiae - Full 
length Dyn2 was cloned from S. cerevisiae S288c as described (Romes, 2012). Briefly, Dyn2 
was cloned into pGEX-6P-2, (GE Healthcare) yielding an N-terminal, cleavable GST tag. 
GST-Dyn2 was expressed in BL21 DE3 (pLysS) and induced using 0.1 mM isopropyl-1-
thio-β-D-galactopyranoside at 18° C for 16 hours. Cells were harvested, resuspended in lysis 
buffer and lysed by sonication. Dyn2 was purified using a Glutathione-S-sepharose column, 
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eluted and incubated with PreScission protease (GE Healthcare) to cleave the GST tag. A 
final purification step was performed using an ion exchange SP Sepharose Fast Flow column 
(GE Healthcare). The Dyn2 peak was collected and exchanged into 50 mM NaCl, 25 mM 
Hepes, pH 6.8, and 0.1% β-mercaptoethanol. The final, purified Dyn2 protein was 
concentrated to 5 mg/mL, snap frozen in liquid nitrogen and stored at -80°C. The final Dyn2 
protein contained an N-terminal GPLGS cloning artifact. 
Cloning, Expression and Purification of Dyn2 mutants - Dyn2 H58K and F76K/Y78E 
mutagenesis was done with the Quikchange method (Strategene) with the following 
complimentary oligonucleotides for the H58K mutant: 5’-
GGATGTCAAATACGGCAATACCTGGAAAGTGATTGTCGGAAAGAACTTTGGG-3’ (where 
the underlined portion codes for the mutated codon) and 5’-
CCCAAAGTTCTTTCCGACAATCACTTTCCAGGTATTGCCGTATTTGACATCC-3’, and the 
complimentary oligonucleotides for F76K/Y78E: 5’-
GTGACACACGAAAAGGGCCATAAAGTTGAATTCTATATCGGTCCACTGGCG-3’ and 5’-
CGCCAGTGGACCGATATAGAATTCAACTTTATGGCCCTTTTCGTGTGTCAC-3’. Both the 
single and double mutants were confirmed by sequencing. The expression and purification of 
Dyn2 H58K and Dyn2 F76K/Y78E follow the same protocols and buffers as for WT Dyn2. 
Synthesis of Pac11 Peptides – Pac11 peptides one (pep1) (YMVSVSVQTDM, 
residues 45-55) and two (pep2) (ITYDKGIQTDQ, residues 75-85), were synthesized at the 
UNC Microprotein Sequencing and Peptide Synthesis Facility. Pep1 was designed with an 
amino terminal tyrosine in order to quantify the peptide concentration once solubilized. 
Lyophilized peptides were solubilized in 50 mM NaCl, 25 mM Hepes, pH 6.8 and 0.1% β-
mercaptoethanol. 
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Crystallization – Final concentrations of 0.5 mM Dyn2 and 0.6 mM Pac11 pep2 were 
incubated together to form a complex in 50 mM NaCl, 25 mM Hepes, pH 6.8, and 0.1% β-
mercaptoethanol for 30 minutes at ambient temperature. Crystals were obtained by the 
hanging drop protocol using 2 µL of the Dyn2-Pac11 pep2 mixture and 1 µL of the 1 mL 
well solution: 0.4 M sodium phosphate monobasic, 0.1 M 1,6-hexanediol, and 25% 
polyethylene glycol 3350. Crystals grew at 20°C into full-sized thin, individual plates in two 
weeks. Crystals were transferred to cryoprotection of well solution supplemented with 20% 
ethylene glycol and flash frozen in liquid nitrogen. 
Data Collection, Structure Determination, and Refinement – Diffraction data were 
collected on Dyn2-Pac11 pep2 crystals at the Advanced Photon Source SER-CAT beamline 
22-ID with 1° oscillations over 180° from a single crystal. Data were indexed, integrated and 
scaled using HKL2000 (Otwinowski, 1997). The structure was determined using the 
AutoMR molecular replacement program (PHENIX crystallographic suite (Adams, 2010)) 
and a modified 4DS1 (Romes, 2012) coordinate file in which a monomeric, apo Dyn2 search 
model was used. The model was built using AutoBuild (PHENIX) (Adams, 2010) and 
refined iteratively through manual builds in Coot (Emsley, 2010) followed by refinement 
runs using phenix.refine (PHENIX) (Adams, 2010). Refinement statistics were monitored 
using a Free R, calculated using 7.8% of the data, randomly excluded from refinement 
(Brunger, 1992). 
Isothermal Microtitration Calorimetry – Pac11 pep2 was exchanged into buffer B 
using G-25 Sephadex Quick Spin Columns (Roche) to remove additional salts. WT Dyn2, 
Dyn2 H58K, and Dyn2 F76K/Y78E were individually exchanged into buffer B as before: 50 
mM NaCl, 25 mM Hepes, pH 6.8, and 0.1% β-mercaptoethanol. Binding was measured by 
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ITC at 26°C on a Microcal AutoITC200 (GE Healthcare). 19 x 2 µL injections of 1.0 mM 
Pac11 pep2 were automatically injected into 200 µL of 50 µM WT Dyn2. The data were 
analyzed with the Origin 7.0 software package (OriginLab) and the resulting isotherm was fit 
to a one-site binding model. The experiment was performed in triplicate and the mean KD 
value with standard deviation is shown in Fig. 2-4A.  
Dyn2 H58K and Dyn2 F76K/Y78E experiments were performed with Pac11 pep2 
solubilized in buffer B (but not desalted) and the same concentrations as for WT Dyn2 and 
did not show binding (Fig. 2-4 F,G). 19 x 2 µL injections of 3.0 mM Pac11 pep2 were 
automatically injected into 200 µL of 300 µM Dyn2 H58K (not desalted) or 300 µM Dyn2 
F76K/Y78E (not desalted). There was significant heat contributed by the Pac11 pep2 in the 
control experiment of 19 x 2 µL injections of 3.0 mM Pac11 pep2 that were automatically 
injected into 200 µL of buffer B. Because each injection produced a significant heat of 
dilution, the control experiment was subtracted from the raw 3.0 mM Pac11 pep2 into 300 
µM Dyn2 H58K or 300 µM F76K/Y78E, and no binding was observed for either experiment 
(Fig. S2-1 C-E).  
Pac11 pep2 was exchanged into buffer B using G-25 Sephadex Quick Spin Columns 
(Roche) to remove additional salts and the resulting concentration was used for further Dyn2 
mutant experiments. 19 x 2 µL injections of 0.5 mM Pac11 pep2 were automatically injected 
into 200 µL of 50 µM Dyn2 H58K or 50 µM Dyn2 F76K/Y78E and no binding was 
observed (Fig. S2-1 A,B).  
 Size Exclusion Chromatography and Multi-Angle Light Scattering – Dyn2 H58K and 
Dyn2 F76K/Y78E were exchanged into buffer B: 50 mM NaCl, 25 mM Hepes, pH 6.8, and 
0.1% β-mercaptoethanol using 3000 Da Amicon Ultra Spin Concentrators. Dyn2 WT was 
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concentrated to 6.0 mg/mL, Dyn2 H58K was concentrated to 10.0 mg/mL, and Dyn2 
F76K/Y78E was concentrated to 6.0 mg/mL and all three proteins were monitored for 
precipitation during concentration. 50 µL injections of Dyn2 WT, H58K or F76K/Y78E were 
individually injected onto a Superdex 200 10/300 GL size exclusion column in buffer B with 
0.2 g/L sodium azide and then passed consecutively through a Wyatt DAWN HELEOS II 
light scattering instrument and a Wyatt Optilab rEX refractometer. The light scattering and 
refractive index data were used to calculate the weight-averaged molar mass (MW) and the 
mass fraction in each peak using the Wyatt Astra V software program (Wyatt Technology 
Corp.) (Wyatt, 1993). 
Protein Data Bank Accession Number – Coordinates for the Dyn2-Pac11 pep2 
complex have been deposited in the Research Collaboratory for Structural Bioinformatics 
PDB under accession code 4HT6. 
 
Results 
The dynein intermediate chain contains two conserved binding motifs for two Dyn2 
homodimers in lower eukaryotes, or for one Dyn2/Lc8 homodimer and one TcTex 
homodimer in higher eukaryotes. In a sequence alignment of ICs from 12 species of 
eukaryotes ranging from fungi to higher order humans (Fig. 2-1A) the putative LC binding 
domains contain regions of sequence identity. There is one invariant QT motif that is 
preserved among all 12 species and one, more N-terminal QT motif that is conserved among 
fungi but not as highly conserved among higher eukaryotes. The more N-terminally 
conserved Q is a putative light chain binding site for Lc8/Dyn2 in fungi where the QT motif  
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Figure 2-1.    Dynein intermediate chains contain conserved dynein light chain binding 
motifs near the amino terminal coiled-coil domain.  
A. Domain diagrams of dynein intermediate chains from S. cerevisiae and H. sapiens 
demonstrate a conserved amino terminal coiled-coil, a conserved binding site for Dyn2/Lc8 
in S. cerevisiae or TcTex in H. spaiens, a highly conserved binding site for Dyn2/Lc8 
homologs which contains the invariant QT motif, and a carboxy terminus WD repeat domain. 
The H. sapiens intermediate chain also contains a p150Glued-binding site between residues 
1-123. A 12 species sequence alignment demonstrates residues 100% identical (green) and 
greater than 65% identical among all species (yellow). There is also conservation indicated 
among the five yeast species (orange is greater than 80% identical) and among the seven 
higher eukaryotes (purple is greater than 57% identical near the TcTex binding site, dark 
orange is greater than 57% identical near the Lc8 binding site). The reported and predicted 
dynein light chains bind to the intermediate chain with eleven residue motifs as indicated at 
the bottom. Residue numbers are indicated for each species. B. Reported Dyn2/Lc8/TcTex 
binding motifs display a highly conserved QT binding motif except for QV for H. sapiens 
TcTex. 
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is invariant, and a TcTex binding site in higher eukaryotes where QV is prevalent but not 
invariant.  
Lower order eukaryotes, such as fungi only contain one type of dynein LC so both of the 
invariant QT motifs and surrounding conserved sequence are potentially used by Lc8/Dyn2 
for recognition and binding. The higher order eukaryotes maintain a high level of 
conservation surrounding the QT and QV motif (with the exception of D. melanogaster and 
D. discoideum) with residues that are not homologous between the fungi and higher 
eukaryotes’ putative binding sites. Previously reported Lc8/Dyn2 binding sites are 
represented in Fig. 2-1B and demonstrate the prevalence of the QT motif for recognition. 
Although binding motifs other than QT have been shown for Lc8/Dyn2, the five Dyn2 
binding sites from the nuclear pore protein, Nup159, the two yeast IC (Pac11) sites, and the 
two LC binding sites on the human IC demonstrate that the QT motif is most utilized. The 
sequence surrounding the QT motif is highly variable, which illuminates Lc8/Dyn2’s 
promiscuity in protein binding targets. Even though the putative binding sites for TcTex 
share some conservation with the Dyn2 binding site, TcTex and Lc8/Dyn2 do not share any 
sequence homology (Williams, 2005). These two dynein LCs share similar structure (RMSD 
1.6 Å between Lc8 and TcTex in Drosophila), but they are otherwise divergent proteins. 
The Dyn2 and Pac11 pep2 complex forms as the result of a central Dyn2 homodimer 
with two Pac11 pep2 binding at the exterior of the central dimerization site to complete two 
antiparallel β-sheets. The Dyn2 and Pac11 pep2 crystal structure shows two central β-sheets 
(Fig. 2-2A); each composed of four antiparallel strands from one Dyn2 monomer (in order 
β1, β4, β5, β2), a β-strand from the corresponding Dyn2 monomer (β3’) and a Pac11 pep2 β- 
strand (residues 75-85), with two helices from each monomer flanking the β-sheets. There is  
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Figure 2-2.    The structure of Dyn2 in complex with Pac11 pep2 shows a Dyn2 dimer 
bound to two Pac11 pep2s that form the end β-strands on two antiparallel β-sheets 
formed within the core of the Dyn2 dimer.  
A. Cartoon rendering of the Dyn2-Pac11 pep2 quaternary structure shows Dyn2 monomer 
one (chain A) in dark green (β-strands) and dark yellow (α-helices), Pac11 pep2 β-strand one 
(chain B) in dark orange, the second Dyn2 monomer (chain C) in light green (β-strands) and 
light yellow (α-helices), and the second Pac11 pep2 β-strand (chain D) in light orange. A 
two-fold non-crystallographic symmetry operator about the z-axis (90° rotation figure at 
right) shows how the two Dyn2-Pac11 pep2 monomers relate to each other in the asymmetric 
unit. B. Stick rendering of Pac11 pep2 (dark orange) is shown bound in the Dyn2 (gray 
surface on top of cartoon) binding cleft between Dyn2 monomers. 2Fo-Fc electron density 
map of the Pac11 pep2, contoured to 1.5σ, is shown in blue mesh. C. The symmetry mate of 
Dyn2 (chain E) and Pac11 pep2 (chain F) complex completes the dimer from the native chain 
E Dyn2 and F Pac11 pep2. The Cα atoms from the chain E/F dimer (gray) align to an RMSD 
of 0.182 Å (over 168/194 atoms) on the original chains A-D (colored).  
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a two-fold non-crystalographic symmetry operator lengthwise between the β-sheets, which 
relates the Dyn2 monomers to each other rotationally in formation of the dimer. The two 
Pac11 pep2 strands each complete an antiparallel β-sheet of Dyn2 and are parallel to each 
other so the amino terminus of each strand extends in the same direction. The crystal 
structure is a complex of 2 Dyn2 : 2 Pac11 pep2 from crystals that diffracted to 1.90 Å 
resolution in the C2221 space group (Table 2-1). The structure was solved using the Dyn2 
dimer stripped of the bound Nup159 peptide (4DS1) for a molecular replacement model 
(Romes, 2012). The Pac11 pep2 was modeled into clear electron density for all 11 residues 
(Fig. 2-2B). The structure was refined to R and Rfree factors of 16.0% and 21.2%, 
respectively (Table 2-1). The crystallographic asymmetric unit contains three Dyn2 
monomers and three Pac11 pep2s (data not shown). The third Dyn2 and Pac11 pep2 unit is a 
composite dimer with the next symmetry mate showing a slight torque about the y-axis. The 
dimer that is composed of a Dyn2-Pac11 pep2 unit from one symmetry mate and one Dyn2-
Pac11 pep2 unit from another symmetry mate aligns with the original dimer (Fig. 2-2C) to an 
RMSD of 0.182 Å (Ca aligned over 168 out of 194 atoms). 
The Dyn2 and Pac11 pep2 structure shows a conservation of hydrogen bonds and an 
extensive van der Waals network which signifies the importance of the QT motif in Dyn2 
binding the peptide. The Pac11 pep2 binding site is mainly composed of an anti-parallel β-
strand interaction between Dyn2 β3 and the Pac11 pep2 mediated by eight hydrogen bonds 
between the amino and carboxyl groups of the backbone (Fig. 2-3A). The stick diagram of 
this binding site shows there are additional hydrogen bond contributions from the side chains 
of Dyn2 β3 and the Pac11 pep2 as well as R39’ and E38’ from the corresponding Dyn2 
dimer. The positively charged K12 from Dyn2 β1, and the large, hydrophobic Y78, and Y80 
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Figure 2-3.    The crystal structure of Dyn2 in complex with Pac11 pep2 shows an 
extensive hydrogen bonding network that involves backbone/backbone β-strand 
interactions as well as involvement by the residue side chains.  
A. A two-dimensional diagram of the hydrogen bonding network and salt bridges (dashed 
lines) that occur between Pac11 pep2 chain B (orange) and Dyn2 chains A and C (green). B. 
and C. Interaction grids between Pac11 pep2 chain B (top, horizontal) and Dyn2 chains A 
and C (vertical). Outside the grid is displayed the secondary structure (β-strands orange and 
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green, α-helices in yellow) and which chain contains the individual residues. Hydrogen bond 
interactions (distances less than or equal to 3.5 Å) are delineated as backbone/backbone 
(blue), side chain/side chain (pink), and backbone/side chain (red), and van der Waals 
contacts in gray (less than or equal to 4.5 Å). C. Hydrogen bonding network represented 
between Dyn2/Pac11 pep2 is compared to previously reported interaction between Dyn2 and 
Nup159 pep2 (bottom, horizontal axis), so the top half of a grid square represents the Pac11 
pep2 hydrogen bond and the bottom half represents the corresponding Nup159 pep2 
hydrogen bond (Romes, 2012). 
 
(both Dyn2 β4) contribute four total hydrogen bonds. The largest number of Pac11 pep2 
hydrogen bonds and van der Waals contacts are made with Q82 and T83 (Fig. 2-3B). The six 
hydrogen bonds and nine additional van der Waals interactions contribute to the stability and 
specificity of Dyn2 recognizing Pac11 pep2. Dyn2 also binds Nup159 with the same QT 
motif at residues 1123 and 1124 (Fig. 2-3C), and in the same anti parallel β-strand 
configuration (Romes, 2012). Many of the same contacts are made between Dyn2 and 
Nup159 as with Pac11 pep2 even though many of the other residue identities are not 
conserved between Nup159 pep2 and Pac11 pep2. Q82 of Pac11 pep2 makes three of the 
four hydrogen bonds and all of the T83 bonds that are made for Nup159 pep2 to secure 
specificity. All of the Pac11 pep2 and Nup159 pep2 residues make at least one hydrogen 
bond with Dyn2 (with the exception of Pac11 T76 and the conserved G80 in Pac11 and 
G1121 in Nup159). 
WT Dyn2 is primarily a dimer in solution and binds Pac11 pep2 with 620 nM affinity. 
Isothermal microtitration calorimetry of Pac11 pep2 binding to WT Dyn2 shows an average 
binding affinity (KD) of 620 nM ± 270 nM (Fig. 2-4A). The Pac11 pep2 bound WT Dyn2 
exothermically at 26°C, and was fit with a single site binding model. The experiment was 
done in triplicate and averaged with the standard deviation to show good agreement (N = 
1.05 ± 0.02 sites, ∆H = -5175 ± 139 cal/mol, ∆S = 11.3 ± 1.5 cal/mol/deg). Previous 
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Figure 2-4.    Dyn2’s ability to dimerize and bind Pac11 pep2 is abrogated through key 
mutations.  
A. Pac11 pep2 binds to Dyn2 with a 2:2 binding stoichiometry in an exothermic interaction 
and with a KD of 620 nM as measured by isothermal microtitration calorimetry. The upper 
binding isotherm shows 19 x 2 µL injections of 1.0 mM Pac11 pep2 into 200 µL of 50 µM 
Dyn2. The bottom panel shows the data fit to a single binding site model from one of three 
independent experiments, with averaged KD (+/- standard deviation of three experiments).   
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B. The SEC-MALS of WT Dyn2 was measured by a 50 µL injection of 6 mg/mL (green) at 
pH 6.8. The differential refractive index measurements were normalized to the tallest, dimer 
peak (21.6 kDa). The peaks are labeled with the measured molecular weight (dark green) and 
the fraction of total injected mass in each peak (in parentheses). This construct of WT Dyn2 
has a calculated molecular weight of 10,852 Da. C. The crystal structure of Dyn2 is shown in 
ribbons and cylinders (colored as in Fig. 2-2) with H58 from each dimer shown in salmon-
colored sticks. The zoom window shows that the H58 imidazole rings stack 5.4 Å apart. D. 
The crystal structure of Dyn2 (ribbons and cylinders) highlights the location of Dyn2, chain 
A F76 and Y78 (purple sticks) binding to the Pac11 pep2 (electrostatic shown on surface). 
The electrostatic surface of Pac11 pep2 is rendered from -2.0 kBT/e (red) to +2.0 kBT/e 
(blue). E. A 50 µL injection of 10 mg/mL Dyn2 H58K mutant (pink) or 6 mg/mL Dyn2 
F76K/Y78E mutant (light purple) for SEC-MALS at pH 6.8. The differential refractive index 
measurements for each mutant were individually normalized to the tallest peak (H58K to the 
12.6 kDa peak, F76K/Y78E to the 26.1 kDa peak). Each peak shows the measured molecular 
weight (H58K in red, F76K/Y78E in purple) and the fraction of total injected mass in each 
peak (in parentheses) F. and G. ITC of Dyn2 mutations interacting with Pac11 pep2. The 
upper panels show 19 x 2 µL injections of 1.0 mM Pac11 pep2 into 200 µL of 50 µM Dyn2 
H58K (F.), or Dyn2 F76K/Y78E (G.). Neither experiment shows detectable binding of Pac11 
pep2. 
 
Dyn2/Lc8 binding experiments show that WT Dyn2 is capable of binding peptides with 
endothermic or exothermic modes as Dyn2 does with binding Nup159 pep2 endothermically 
at 17.9 µM and Nup159 pep4 exothermically at 13.1 µM (Romes, 2012). Lc8 also binds 
similar length peptides exothermically with KDs between 1 µM for Bmf and 7 µM for nNOS 
(Radnai, 2010). Therefore, Dyn2 binding Pac11 pep2 is more than an order of magnitude 
tighter than binding Nup159 peptides and on the tighter side of the Lc8 homologs. The first 
Pac11 binding site was synthesized to measure binding, but it was too hydrophobic to 
solubilize for ITC experiments. In the same buffer conditions as the binding experiments we 
show that WT Dyn2 forms mostly a dimer at pH 6.8 as measured by SEC-MALS (Fig. 2-
4B), as was previously described in Romes, 2012. Here we show that 93% of the total 
injected mass was found to form a dimer at 21.6 kDa (calculated molecular weight of the WT 
Dyn2 monomer is 10.852 kDa, with the GPLGS cloning fragment). 7% of the total injected 
mass eluted in a wide, but small peak, which usually indicates an inability to separate two 
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species. The differential refractive index was used to calculate the molecular weight of this 
peak at 35.8 kDa, this suggests it is composed of trimer and tetramer of WT Dyn2. 
 An H58K mutation in the Dyn2 dimerization site and a F76K/Y78E double mutation 
at the peptide-binding site temper Dyn2’s ability to dimerize and/or bind the Pac11 pep2. A 
single mutation in the dimerization site of Lc8 at H55 to a lysine (K) was previously reported 
to preference an Lc8 monomer at pH 3-8 where Lc8 is mostly at dimer at pH 4-8 (Nyarko, 
2005). We hypothesized that the dimerization in the equivalent H58 lysine mutant of Dyn2 
would cause a similar preference for a Dyn2 monomer at neutral pH. H55 in Lc8 acts as a 
switch that favors a folded monomer when the imidazole ring is in the protonated form, 
below the pKa of this particular histidine at pH 4.5 (Nyarko, 2005). In Dyn2 H58 the 
imidazole rings are a distance of 5.4 Å apart in the central core of the dimerization interface 
(Fig. 2-4C). When H55 in Lc8 (or H58 in Dyn2) is mutated to a residue with a pKa not 
sensitive to this particular pH region the decoupled protonation state stays as a monomer or 
dimer at any pH that allows Dyn2 to maintain the fold. When we mutated H58 to a lysine, the 
charge repulsion caused Dyn2 to preferentially form monomers at pH 6.8 (Fig. 2-4E, 
pink/red). The SEC-MALS for Dyn2 H58K shows that 74% of the Dyn2 is in the monomer 
form at 12.6 kDa (Dyn2 H58K calculated molecular weight is 10.843 kDa) and 26% in the 
dimer population at 19.5 kDa. Dyn2 H58K in the same buffer was also unable to bind Pac11 
pep2 at the same concentrations as measured for the WT Dyn2 (Fig. 2-4F). Small 
endothermic peaks were observed in the Dyn2 H58K/Pac11 pep2 binding reaction that are 
attributed to the high concentration of Pac11 pep2 which was offset by the large exothermic 
contribution of Pac11 pep2 binding to the WT Dyn2 in Fig. 2-4A. To ensure that Pac11 pep2 
was not able to bind to Dyn2 H58K we increased the concentrations of Dyn2 H58K and 
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Pac11 pep2 to the highest concentrations attainable that were still soluble. At 0.3 mM Dyn2 
H58K and 3.0 mM Pac11 pep2 there was a significant exothermic contribution by the Pac11 
pep2 (Fig. S2-1D) as determined by a control of 3.0 mM Pac11 pep2 injected into buffer 
(Fig. S2-1C). After subtracting the control experiment from the 3.0 mM Pac11 pep2/0.3 mM 
Dyn2 H58K binding experiment it was evident that no significant binding was taking place. 
Since the Pac11 pep2 shows such a large exothermic heat of dilution at high concentrations, 
we additionally desalted Pac11 pep2 with a Sephadex desalting column and measured 0.5 
mM desalted Pac11 pep2 injected into 50 µM Dyn2 H58K and found there was no significant 
binding (Fig. S2-1A). 
 A double mutation of Dyn2 at the peptide-binding site was designed specifically for 
Pac11 pep2’s electrostatic profile (Fig. 2-4D). Pac11 pep2 contains an electropositive charge 
(K79) and an electronegative charge (D84) that form van der Waals contacts with F76 and 
Y78 of Dyn2 (Fig. 2-3B) but the F76 and Y78 are not predicted to disturb the dimerization 
site of Dyn2. We designed Dyn2 mutations to have charge repulsions so that F76 is mutated 
to lysine to oppose K79 on Pac11, and Y78 is mutated to glutamate to oppose the D84 
according to the crystal structure. The SEC-MALS for Dyn2 F76K/Y78E demonstrates that 
at pH 6.8 the dimer is still maintained with 52% of the total mass fraction at 26.1 kDa (Dyn2 
F76K/Y78E calculated molecular weight is 10.799 kDa) (Fig. 2-4E, purple). There are also 
two other oligomer populations at 51.3 kDa (37% mass fraction) and 79.2 kDa (10% mass 
fraction) that are inexplicably more prominent in the double mutant than in the WT Dyn2 
(Fig. 2-4B). Dyn2 F76K/Y78E was unable to bind Pac11 pep2 as measured by ITC at the 
same concentrations as WT (Fig. 2-4G). We also measured Dyn2 at 0.3 mM Dyn2 
F76K/Y78E with 3.0 mM injected Pac11 pep2 (Fig. S2-1E) and saw a similar Pac11 pep2 
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dependence in the control that was corrected by subtracting the control heats of dilution from 
the Dyn2 F76K/Y78E/Pac11 pep2 reaction and resulted in no significant binding. Measuring 
0.5 mM desalted Pac11 pep2 into 50 µM Dyn2 F76K/Y78E also resulted in no significant 
binding as was seen in all of Dyn2 mutant experiments (Fig. S2-1B). These results indicate 
that Dyn2 H58K shows consistent behavior to the Lc8 counterpart of forming mostly a dimer 
that in this case is unable to bind the Pac11 pep2. The Dyn2 F76K/Y78E is able to maintain 
the homodimer in solution at pH 6.8, but peptide binding is abrogated for Pac11 pep2. 
 
Discussion 
 The dynein light chain, Dyn2 was first characterized as a dynein associating protein, 
but studies have not been able to determine Dyn2’s purpose, other than as a general 
scaffolding protein that binds to the dynein intermediate chain, Pac11. The dynein 
intermediate chain has been shown to abrogate force production of the dynein complex when 
bound to NudE (McKenney, 2011), but whether Dyn2 or other dynein light chains are 
present and necessary for this process is unclear. This and previous studies have determined 
through sequence alignments and deletion studies that dynein intermediate chains contain 
more than one possible binding site for the dynein light chains near the N-terminus. The 
intermediate chain in higher eukaryotes has been shown to bind one of each of the three 
dynein light chains, however yeast species only contain the Dyn2 dynein light chain which 
binds in two putative locations that align with the Lc8 and TcTex binding sites on the IC in 
higher eukaryotes (Stutchell-Brereton, 2011). Here we show that the Dyn2/Lc8 binding 
sequence motif is highly conserved across many species of yeast and higher metazoans, but 
the second Dyn2 binding site in yeast diverges in higher metazoans to form the homologous 
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TcTex binding location. We confirm that Dyn2 binds Pac11 at the second Dyn2 binding site 
exothermically through isothermal microtitration calorimetry. We report that Dyn2 binds 
Pac11 pep2 with a KD of 620 nM, which is bound more tightly than previous Dyn2 binding 
interactions, and among the tightest found for Dyn2/Lc8 binding to date. We also obtained a 
1.90 Å crystal structure of a Dyn2 homodimer bound to two Pac11 pep2. The co-crystal 
complex of Dyn2 and Pac11 pep2 showed an extensive hydrogen-bonding network that 
supports the result that Dyn2 binds Pac11 pep2 exothermically. The hydrogen-bonding 
network compares to a previous structure of Dyn2 bound to the nuclear pore protein, Nup159 
to illuminate the importance of the QT motif in binding to Dyn2. Glutamine 82 and threonine 
83 in Pac11 pep2 each contribute three hydrogen bonds in the Pac11 network, and the 
corresponding Q1123 in Nup159 pep2 contributes four hydrogen bonds with three from 
T1124 to form the Dyn2-specific network. Both the ITC binding studies and co-crystalization 
of Dyn2 and Pac11 pep2 support our hypothesis that Dyn2 acts as a dimerization machine to 
assist Pac11 homodimerization through mediation of Dyn2. We confirmed through an H58K 
point mutation in the core of the Dyn2 structure that Dyn2 homodimerization is necessary to 
bind the Pac11 pep2, as has been shown for the higher eukaryote homolog, Lc8 (Wang, 
2003). We showed through SEC-MALS that Dyn2 H58K forms primarily a monomer in 
solution that was unable to bind the Pac11 pep2 using a number of different concentrations 
and conditions in ITC. This histidine to lysine mutation was shown to mimic the behavior of 
an Lc8 phosphomimetic which preferences the Lc8 monomer in solution (Song, 2008). 
Phosphorylation of Lc8 therefore regulates the dimerization and binding to target proteins by 
dissociating the dimer, much like protonation of H55 (or H58 in Dyn2) dissociates the dimer. 
Additionally we designed a F76K/Y78E double point mutant in Dyn2 that shows the ability 
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to dimerize in solution through SEC-MALS, but the double mutation abrogates the ability of 
Dyn2 to bind to the Pac11 pep2. The F76K/Y78E Dyn2 mutant was designed specifically for 
ablating the interaction with Pac11 pep2, however we hypothesize that this specific mutation 
would also be useful for Dyn2 binding sites that contain a (+)xxQT(-) motif (where + 
indicates a positively charged residue K/R/H and – indicates a negatively charged D/E). This 
F76K/Y78E Dyn2 mutant also showed an unexplained higher population of larger order 
oligomers than the corresponding SEC-MALS of the Dyn2 WT at the same concentrations. 
We hypothesize that these higher order oligomers form in the F76K/Y78E mutant due to an 
increase in ionic interactions. The ionic strength of the buffer is low with only 50 mM NaCl, 
so we could test our hypothesis by increasing the NaCl concentration of the buffer to 
determine whether the pronounced higher oligomer peaks remain, indicating oligomer 
associations through ionic interactions. In the future we aim to utilize the H58K and 
F76K/Y78E mutants to determine whether Dyn2’s interaction with Pac11 modulates the in 
vitro processivity and localization of the dynein complex through Dyn2’s function as a 
dimerization machine for Pac11. 
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Supplemental Figure 2-1.    Pac11 pep2 does not bind to Dyn2 H58K or Dyn2 
F76K/Y78E as measured by ITC. 
A. and B. 0.5 mM desalted Pac11 pep2 was injected into 200 µL of 50 µM Dyn2 H58K or 
Dyn2 F76K/Y78E in 19 x 2 µL injections and no measurable binding was observed as 
indicated by the relatively straight line of integrated heats of dilution in the bottom panels. C. 
The control of 19 x 2 µL injections of 3.0 mM Pac11 pep2 into 200 µL of buffer B showed 
significant heats of dilution (upper panel) and a trend upon integrating values (lower panel). 
D. and E. 19 x 2 µL injections of 3.0 mM Pac11 pep2 were introduced to 200 µL of 0.3 mM 
Dyn2 H58K or Dyn2 F76K/Y78E showing significant heats of dilution in the top panels. The 
values in the control lower panel (C.) were subtracted from D. and E. heats of dilution to 
correct for Pac11 pep2 into buffer B heat contribution (lower panels). 
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CHAPTER 3 
 
THE STRUCTURE AND BINDING MODE OF THE DYNEIN LIGHT CHAIN, LC8, 
WITH AN ESSENTIAL CENTRIOLE DUPLICATION FACTOR, ANA2 
 
Preface 
 This work is a manuscript in progress with unfinished experiments. Karen Plevock 
cloned Lc8 into the pGEX-6P-2 vector. Lauren Slevin assisted me in the isothermal 
microtitration calorimetry experiments and preparing crystals for diffraction. Lauren also 
performed fluorescence microscopy experiments on Lc8 and Ana2 localization in S2 cells, 
but that work is not reflected here. I designed and performed the remaining biophysical 
experiments and protein preparation. My advisor, Kevin Slep, and I designed the binding and 
crystallization experiments, and Kevin Slep, Lauren Slevin and I wrote and edited the 
manuscript. 
 Romes, EM, Slevin, LK, Plevock, K, and Slep, K. (manuscript in progress). 
 
Summary 
 Centriole duplication is an important process in the life cycle of a cell, which is 
highly regulated so that a cell is able to properly segregate chromosomal DNA and prevent 
genomic instability and nuclear fallout. Centrioles nucleate a procentriole orthogonal to the 
existing centriole (Nigg, 2011) and proceed through a duplication cycle, which includes 
initiation/licensing, elongation, termination, and new centriole maturation (Azimzadeh, 
2012). The initiation step in the cycle utilizes the highly regulated Sas6 to form the initial 
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structure of the procentriolar cartwheel (Brito, 2012). Sas6 binds to another essential 
centriole duplication protein, Ana2, which is responsible for nucleating a single procentriole 
off of a mother centriole, and without which a cell is likely to have fewer than two centrioles 
during mitosis (Arquint, 2012). Ana2 binds to a dynein light chain, Lc8 to regulate spindle 
positioning and to assist Ana2 in dimerization (Wang, 2011). Here we demonstrate that Lc8 
binds Ana2 exothermically at two locations with one canonical QT binding motif (pep1) and 
an affinity of 0.54 µM, and the second site is a QC motif (pep2) with a binding affinity of 
12.7 µM. We present the 1.83 Å crystal structure of Lc8 bound to Ana2 pep1, which 
demonstrates that Lc8 binds Ana2 pep1 in a similar manner as previously described crystal 
structures. We will continue to refine this crystal structure and the structure of Lc8 bound to 
Ana2 pep2 to answer whether the previously uncharacterized non-canonical QC binding 
motif displays a different hydrogen-bonding interaction network than what has been 
previously described. We also aim to determine whether Lc8 functions as a dimerization 
machine responsible for dimerizing Ana2 at the site of centriole duplication. 
 
Experimental Procedures 
Cloning and Expression of full length Lc8 
Full length Lc8 was cloned from Drosophila melanogaster into the pGEX-6P-2 expression 
vector (GE Healthcare) using the polymerase chain reaction. pGEX-6P-2-Lc8 was 
transformed into E. coli BL21 DE3 (pLysS) and grown under ampicillin selection in 6 L of 
LB media at 37°C. At an optical density of 0.8 (600 nm), GST-Dyn2 expression was induced 
using 0.1 mM isopropyl-1-thio-β-D-galactopyranoside for 16 hours at 18°C. Cells were 
harvested by centrifugation at 2100 x g for 10 min. at 4°C and the pellets resuspended in 
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buffer A: 150 mL of 25 mM Tris, pH 8.0, 300 mM NaCl, and 0.1% β-mercaptoethanol, and 
stored at -20°C. 
Protein Purification 
Lc8 was purified as described in Romes, 2012. Briefly, Lc8 was expressed in BL21 DE3 
(pLysS) cells at 18° C for 16 hours. Cells were lysed by sonication and the supernatant was 
first purified on a Glutathione-S-sepharose column and the GST tag was cleaved with 
PreScission protease (GE Healthcare). The cleaved protein was additionally purified by SP 
Sepharose Fast Flow column (GE Healthcare) and the peak fractions were exchanged into the 
final MES buffer: 25 mM MES at pH 6.0, 50 mM NaCl, and 0.1% β-mercaptoethanol. Lc8 
was concentrated to about 0.5 mM and snap frozen in liquid nitrogen and stored at -80°C 
until further use. The final Lc8 contains an N-terminal GPLGS cloning artifact. 
Synthesis of Ana2 Peptides 
Ana2 peptides were synthesized at the UNC Microprotein Sequencing and Peptide Synthesis 
Facility and lyophilized peptides were reconstituted in final MES buffer. The sequences for 
Ana2 peptides are pep1 (NYTICAGTQTDP, residues 159-168) and pep2 
(NYSSTTGTQCDI, residues 237-246), which includes an N-terminal exogenous Asn and 
Tyr for peptide concentration determination. 
Crystallization 
Lc8 and Ana2 pep1 complex: final concentrations of 0.5 mM Lc8 and 0.6 mM Ana2 pep1 in 
final MES buffer were incubated for 30 minutes on ice. Crystallization followed the hanging 
drop protocol using 2 µL of the Lc8-Ana2 pep1 mixture and 2 µL of the 1 mL well solution: 
0.3 M magnesium acetate tetrahydrate, 0.1 M cacodylic acid sodium salt, pH 6.5 and 26% 
(w/v) polyethylene glycol 8000. Crystals grew at 20°C into rods within three days and 
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remained at full size for up to three weeks. Crystals were transferred into fomblin oil (Sigma) 
for cryoprotection and flash frozen in liquid nitrogen. 
Lc8 and Ana2 pep2 complex: final concentrations of 0.75 mM Lc8 and 0.9 mM Ana2 pep2 
in final MES buffer were incubated for 30 minutes on ice. Crystallization followed the 
hanging drop protocol using 2 µL of the Lc8-Ana2 pep2 mixture and 2 µL of the 1 mL well 
solution: 20% (w/v) polyethylene glycol 3350 and 0.35 M potassium phosphate monobasic. 
Crystals grew at 20°C into thin plates within seven days. Crystals were transferred into 
fomblin oil (Sigma) for cryoprotection and flash frozen in liquid nitrogen. 
Data Collection, Structure Determination, and Refinement 
Diffraction data were collected on Lc8-Ana2 pep1 and pep2 crystals at the Advanced Photon 
Source SER-CAT beamline 22-ID with 1° oscillations over 180° from a single crystal. Data 
were indexed, integrated and scaled using HKL2000 (Otwinowski, 1997). The Lc8-Ana2 
pep1 structure was determined using the AutoMR molecular replacement program (PHENIX 
crystallographic suite (Adams, 2010)) and a modified 2PG1 (Williams, 2007) coordinate file 
in which a monomeric, apo Lc8 search model was used. The model was built using 
AutoBuild (PHENIX) (Adams, 2010) and refined iteratively through manual builds in Coot 
(Emsley, 2010) followed by refinement runs using phenix.refine (PHENIX) (Adams, 2010). 
Refinement statistics were monitored using a Free R, calculated using 5.7% of the data, 
randomly excluded from refinement (Brunger, 1992). 
Isothermal Microtitration Calorimetry 
ITC experiments were carried out at 26°C in final MES buffer on a Microcal AutoITC200 
(GE Healthcare). Lyophilized peptides were solubilized in final MES buffer. 19 x 2 µL 
injections of 1.0 mM Ana2 pep1 were automatically injected into 200 µL of 50 µM Lc8 and 
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2.0 mM pep2 was automatically injected into 200 µL of 100 µM Lc8. The resulting binding 
isotherms (Fig. 3-1) were analyzed using the Origin 7.0 software package (OriginLab) and 
were fit to a one-site binding model. Ana2 peptide control experiments were performed to 
determine heat of dilution contribution where 19 x 2 µL injections of 1.0 mM Ana2 pep1 or 
2.0 mM Ana2 pep2 was injected into 200 µL of final MES buffer. The resulting binding 
isotherm for the Ana2 pep1 control was not significant to subtract from the raw experimental 
values, so the final 5 injection values (where binding was saturated out) were averaged and 
this value was subtracted from each injection as an internal control. Ana2 pep2 external 
control registered a significant endothermic heat contribution so these control values were 
individually subtracted from the raw experimental values for Lc8 binding Ana2 pep2 (see 
Fig. S3-1 for control binding isotherms). Experiments were conducted in triplicate, the 
internal or external controls were subtracted, and the resulting heats of dilution were 
averaged to determine respective mean KD values with standard deviations as shown. 
 
Results 
Lc8 binds the traditional QT motif, Ana2 pep1 with 0.54 µM affinity and the non-
traditional QC motif, Ana2 pep2 with 12.7 µM affinity. The interactions between Lc8 and 
Ana2 pep1/pep2 were determined by ITC to investigate strength and mode of binding. 
Previous studies have shown that Dyn2 dimers (the S. cerevisiae Lc8 homolog) are capable 
of binding Nup159 target peptides with two different binding modes (Romes, 2012). 
Although most Lc8 binding interactions determined to date are exothermic in nature, Lc8 is 
also capable of binding target peptides with affinities ranging from 0.06 µM (Swallow) to 
100 µM (Pak1) (Benison, 2009; Williams, 2007). We determined that Lc8 binds to both 
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Ana2 pep1 and Ana2 pep2 with an exothermic binding mode (Fig. 3-1 A,B), which indicates 
they both form extensive hydrogen bonding networks with Lc8. Ana2 pep1 bound to Lc8 
with 0.54 µM affinity (Fig. 3-1A), which is comparable to 0.62 µM affinity that Pac11 pep2 
binds to Dyn2 (Romes, unpublished). The Ana2 pep1 heats of dilution did not contribute 
significantly to the overall binding of Lc8 as determined by an external control (Fig. S3-1A), 
so an internal subtraction of the saturated peaks at the end of the binding curve was sufficient 
  
Figure 3-1.    Lc8 interacts with two Ana2 peptides with an exothermic binding mode 
but exhibits different affinities.  
The upper panel displays the injection thermograms of Lc8 bound over the period of time 
(min). The lower panel displays the integrated heats of dilution and the values were fit to a 
one-site binding model using Origin 7.0 software (OriginLab). A. 19 x 2 µL injections of 1.0 
mM Ana2 pep1 were automatically injected into 200 µL of 50 µM Lc8 to measure the 
thermal heats of dilution. The exothermic profile of the binding curve was internally 
corrected and fit with Ana2 pep1 binding Lc8 with 0.54 µM affinity. B. 19 x 2 µL injections 
of 2.0 mM Ana2 pep2 were automatically injected into 200 uL of 100 µM Lc8 to measure 
binding heats. The resulting isotherm was externally corrected and fit with Ana2 pep2 
binding Lc8 with 12.7 µM affinity. 
Lc8-Ana2 pep1: KD = 0.54 ± 0.28 µM, ∆H = -1.08E4 cal/mol, ∆S = -7.1 cal/mol/deg, N = 
0.61 sites; Lc8-Ana2 pep2: KD = 12.7 ± 1.5 µM, ∆H = -8700 cal/mol, ∆S = -6.8 cal/mol/deg, 
N = 0.94 sites. 
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for eliminating the contribution of Ana2 pep1 heat in buffer. Lc8 bound to Ana2 pep2 less 
strongly with a KD of 12.7 µM (Fig. 3-1B). The concentrations necessary to accurately 
measure Ana2 pep2 binding to Lc8 were higher than for pep1, and injecting Ana2 pep2 into 
buffer (Fig. S3-1B) contributed to the measurable heat of the system, so values from the 
external control of Ana2 pep2 injections into buffer were individually subtracted from each 
binding injection for Ana2 pep2 into Lc8. 
Lc8 forms crystallized complexes with Ana2 peptides, but only Ana2 pep1 was able to 
resolve a structure without further optimization. We were able to optimize crystallization and 
x-ray diffraction conditions for the complex of Lc8-Ana2 pep1 to process the raw diffraction 
and solve the structure to 1.83 Å in the P212121 space group. The diffraction data were 
indexed, integrated and scaled with HKL2000 (Otwinowski, 1997) to obtain a 1.83 Å data set 
with 96% completion and 12.3 <I/σ> (signal over noise). We modified pdb 2PG1 (Williams, 
2007) to contain only an Lc8 monomer for a molecular replacement solution for the Lc8-
Ana2 pep1 structure. There are four Lc8-Ana2 pep1 molecules in the asymmetric unit. Each 
asymmetric unit contains two Lc8 homodimers with each homodimer binding two Ana2 pep1 
within the medial peptide-binding cleft. The Ana2 pep1 electron density was strongly 
indicated as binding to all four Lc8 monomers and was built in de novo and has currently 
been refined to 18.2 R working and 22.6 Rfree values. 
The crystal morphology of Lc8-Ana2 pep2 was a series of thin, epitaxial plates, 
which were very different from pep1 morphology. The epitaxial plates indicated that the 
twinned crystals were diffracting as split and smeared spots in the x-ray diffraction pattern.  
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As a result, we were unable to resolve the peaks for proper indexing and further crystal 
optimization will be needed to resolve these issues. 
The Lc8-Ana2 pep1 crystal structure reveals that Lc8 binds to Ana2 pep1 in the same 
binding pocket and orientation as previous Lc8 structures. The crystal structure of the Lc8 
homodimer bound to the dynein intermediate chain (Williams, 2007) was previously shown  
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Figure 3-2.    The crystal structure of the Lc8-Ana2 pep1 is a 2:2 complex formed by an 
Lc8 homodimer binding two Ana2 pep1.  
 
A. and B. The Lc8 monomer is composed of two α-helices from each monomer on the top 
and bottom of two antiparallel β-sheets. Chain A monomer of Lc8 is represented in dark 
colors with α-helices in dark green cylinders and β-strands in dark blue cartoon. Chain B is 
the second Lc8 monomer in light colors with helices in light green cylinders and β-strands in 
light blue cartoon. The Ana2 pep1 are in dark yellow (Chain C) and light yellow (Chain D) 
cartoon. B. The Lc8-Ana2 pep1 complex is turned 90 degrees about the y-axis to demonstrate 
the two-fold non-crystallographic symmetry operator through the center of the dimer about 
the z-axis. 
 
to be two α-helices from each monomer flanking two β-sheets that are parallel, but 
composed of antiparallel β-strands (Fig. 3-2A). Each β-sheet is composed of five β-strands in 
order of β1-β4-β5-β2-β3’ where the ultimate β-strand is contributed by the corresponding 
dimer pair. There is a non-crystallographic symmetry operator that relates the Lc8-Ana2 
monomers to each other through a two-fold rotation (Fig. 3-2B). The Lc8 binding site for 
peptides with a canonical or non-canonical QT motif is a β-strand-β-strand interaction where 
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the peptide completes the β-sheet following the β3’ strand. We found that the 1.83 Å crystal 
structure of the Lc8-Ana2 complex forms the same secondary structures and Lc8 binds the 
Ana2 pep1 in the same binding pocket. 
 
Discussion 
 Previous work shows that Ana2 is essential for localizing Sas6 to a procentriole 
during centriole duplication (Stevens, 2010). Ana2/STIL/Sas-5 have proven to be necessary 
for promoting the growth of only one procentriole on a mother, a process which ensures that 
the proper number of centrioles are formed to prevent genomic instability due to improper 
chromosome segregation (Nigg, 2011). In addition, centriole position is crucial to 
determining spindle orientation which is especially important in polarized, dividing cells 
(Wang, 2011). Ana2 was shown to interact with a dynein light chain, Lc8, and both are 
necessary for properly positioned mitotic spindles (Wang, 2011). Wang, et al. determined 
that the N-terminus and central coiled-coil of Ana2 are important for interacting with Lc8, 
and the N-terminal 274 residues are sufficient for Ana2’s function in centriole duplication 
and positioning mitotic spindles (Wang, 2011). Our work aims to better define the role for 
the Lc8-Ana2 interaction in centriole duplication and positioning spindles, and specific 
regions required for this interaction to occur. 
 We determined that Lc8 binds two locations on Ana2 in a similar manner as previous 
examples of Lc8 bind to target peptides. We utilized ITC to show that Lc8 binds two 
different QT motifs, one canonical and one non-canonical. Both of the binding motifs are 
within the N-terminal region that Wang, et al. determined to be sufficient for Ana2’s function 
in centrioles. The more N-terminal binding motif is canonical because it contains both Q and 
  72
T at residues 165 and 166, while the second Ana2 peptide contains the non-canonical QC 
motif at residues 243 and 244. The canonical Ana2 pep1 bound Lc8 with a KD of 0.54 µM, 
and the non-canonical Ana2 pep2 bound Lc8 with a KD of 12.7 µM. They both exhibited 
common exothermic binding modes, which are indicative of a strong hydrogen-bonding 
network between Lc8 and Ana2. The structural complex of Lc8 and Ana2 pep1 confirmed 
this extensive hydrogen-bonding network. 
 The x-ray crystal structure of Lc8 and Ana2 pep1 demonstrates that Lc8 is able to 
bind Ana2 at the first putative binding site in a manner consistent with other Lc8 structures. 
We aim to continue refining this Lc8-Ana2 pep1 complex in order to obtain a structure 
sufficient for publication and to properly determine the individual binding interactions that 
occur through the hydrogen-bonding network. We have determined through structural 
analysis of this Lc8-Ana2 pep1 complex that the Lc8 binding pocket is not as wide as the 
Dyn2 binding pocket from Romes, 2013 (data not shown). Peptides that are able to bind in 
the Dyn2 binding pocket may not be able to do so in the Lc8 binding pocket due to steric 
hindrance. We hypothesize that the binding pocket for Lc8 binding to Ana2 pep2 may be 
slightly shifted to accommodate the non-canonical cysteine instead of a sterically smaller, 
canonical threonine in Ana2 pep1. 
 We will continue to optimize conditions for Lc8 and Ana2 pep2 crystallization and x-
ray diffraction. We hypothesize that much of the hydrogen-bonding network will be the same 
between the Ana2 pep1 and Ana2 pep2 structures with Lc8, but that small differences will 
account for the difference in binding affinity. We are also interested in refining the regions of 
Ana2 that play a role in centriole duplication and whether Lc8’s role as a dimerization 
machine for Ana2 is essential for their individual roles in mitotic spindle orientation. 
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Supplemental Figure 3-1.    Ana2 peptide ITC controls were necessary to determine the 
peptide contribution to the overall heat of dilution in each injection.  
A. 19 x 2 µL injections of 1.0 mM Ana2 pep1 were automatically injected into final MES 
buffer to measure the heats of dilution for the control (upper panel). The lower panel shows 
that the integrated heats of dilution do not show significant values for subtracting from the 
experimental values of Ana2 pep1 into Lc8. B. Heats of dilution for 19 x 2 µL injections of 
2.0 mM Ana2 pep2 (upper panel) show significant heat contributions that change over the 
course of the control experiment. The integrated injection peaks (lower panel) were then 
individually subtracted from each value in the experiment of 2.0 mM Ana2 pep2 into 0.1 mM 
Lc8. 
 
 
 
 
 
CHAPTER 4 
 
THE STRUCTURE OF A YEAST DYN2-NUP159 COMPLEX AND THE 
MOLECULAR BASIS FOR THE DYNEIN LIGHT CHAIN – NUCLEAR PORE 
INTERACTION 
 
Preface 
 This work was previously published in Journal of Biological Chemistry. Ashutosh 
Tripathy helped me design and assisted me in the size exclusion chromatography-multi-angle 
light scattering experiments as well as the isothermal microtitration calorimetry. I performed 
the remaining experiments. My advisor, Kevin Slep, designed the project and we wrote and 
edited the manuscript. 
 Romes, EM, Tripathy, A, Slep, K. (2012) J. Biol. Chem. 287 (19): 15862-73. 
 
Summary 
 The Nuclear Pore Complex gates nucleocytoplasmic transport through a massive, 
eight-fold symmetric channel capped by a nucleoplasmic basket and structurally unique, 
cytoplasmic fibrils whose tentacles bind and regulate asymmetric traffic. The conserved 
Nup82 complex, composed of Nsp1, Nup82 and Nup159, forms the unique cytoplasmic 
fibrils that regulate mRNA nuclear export. While the nuclear pore complex plays a 
fundamental, conserved role in nuclear trafficking, structural information about the 
cytoplasmic fibrils is limited. Here, we investigate the structural and biochemical interactions 
between S. cerevisiae Nup159 and the nucleoporin: Dyn2. We find that Dyn2 is 
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predominantly a homodimer and binds arrayed sites on Nup159, promoting Nup159’s 
parallel homodimerization. We present the first structure of Dyn2, determined at 1.85 Å 
resolution, complexed with a Nup159 target peptide. Dyn2 resembles homologous metazoan 
dynein light chains, forming homodimeric composite substrate binding sites that engage two 
independent 10 residue target motifs, imparting a β-strand structure to each peptide via anti-
parallel extension of Dyn2’s core β-sandwich. Dyn2 recognizes a highly conserved QT 
motif, while allowing sequence plasticity in the peptide’s flanking residues. Isothermal 
titration calorimetric analysis of Dyn2’s comparative binding to two Nup159 target sites 
shows similar affinities (18 and 13 µM), but divergent thermal binding modes. Dyn2 
homodimers are arrayed in the crystal lattice, likely mimicking Dyn2’s arrayed architecture 
on Nup159’s multivalent binding sites. Crystallographic inter-dimer interactions potentially 
reflect a cooperative basis for Dyn2-Nup159 complex formation. Our data highlights the 
determinants that mediate oligomerization of the Nup82 complex and promote a directed, 
elongated cytoplasmic fibril architecture. 
 
Experimental Procedures 
 Cloning and Expression of Full Length Dyn2 from S. cerevisiae - Full length Dyn2 
was cloned from S. cerevisiae S288c into the pGEX-6P-2 expression vector (GE Healthcare) 
using the polymerase chain reaction and BamHI and EcoRI engineered flanking restriction 
sites. The Dyn2 insert was sequence verified against Genbank accession NC_001136. pGEX-
6P-2-Dyn2 was transformed into E. coli BL21 DE3 (pLysS) and grown under ampicillin 
selection in 6 L of LB media at 37°C. At an optical density of 0.8 (600 nm), GST-Dyn2 
expression was induced using 0.1 mM isopropyl-1-thio-β-D-galactopyranoside for 16 hours 
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at 18°C. Cells were harvested by centrifugation at 2100 x g for 10 min. at 4°C and the pellets 
resuspended in buffer A: 150 mL of 25 mM HEPES, pH 6.8, 300 mM NaCl, and 0.1% β-
mercaptoethanol, and stored at -20°C. 
 Protein Purification - Resuspended cell pellets were thawed and lysed by sonication 
at 4°C. 0.1 mM phenylmethylsulfonyl fluoride was added to the lysate and cell debris was 
pelleted by centrifugation at 23,000 x g for 45 min. Supernatant was loaded onto a 5 ml 
Glutathione Sepharose Fast Flow affinity column (GE Healthcare). GST-tagged Dyn2 was 
eluted from the glutathione column with 100 ml of 3 mM glutathione pH 8.0 in buffer A. The 
GST-Dyn2 eluate was exchanged into buffer B (25 mM HEPES, pH 6.8 and 0.1% β-
mercaptoethanol) using an Amicon Ultra 10 kDa spin concentrator (Millipore) and incubated 
for 16 hours with PreScission protease (GE Healthcare). The cleaved protein was loaded onto 
an SP Sepharose Fast Flow column (GE Healthcare) and eluted over a linear 0-1 M NaCl 
gradient in buffer B. Dyn2 peak fractions were pooled and exchanged into 50 mM NaCl, 25 
mM HEPES, pH 6.8, and 0.1% β-mercaptoethanol using an Amicon Ultra 3 kDa spin 
concentrator (Millipore) and concentrated to 5 mg/mL, snap frozen in liquid nitrogen and 
stored at -80°C. All purification procedures were executed at 4°C. The final, purified Dyn2 
protein contained an N-terminal GPLGS cloning artifact. 
 Synthesis of Nup159 Peptides - Nup159 pep1 (YSADFDVQTSL, residues 1103-
1113), pep2 (NYAESGIQTDL, residues 1116-1126), pep3 (YVKHNSTQTVK, residues 
1141-1151), pep4 (YAVDNGLQTEP, residues 1153-1163), and pep5 (YTCNFSVQTFE, 
residues 1165-1175) (Fig. 4-1C) were synthesized at the UNC Microprotein Sequencing and 
Peptide Synthesis Facility. Pep1, pep3, pep4 and pep5 were designed with an amino terminal 
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tyrosine in order to quantify the peptide concentration once solubilized. Lyophilized peptides 
were solubilized in 50 mM NaCl, 25 mM HEPES, pH 6.8 and 0.1% β-mercaptoethanol. 
 Crystallization - 1.0 mM Dyn2 was incubated with 1.5 mM Nup159 pep2 in 50 mM 
NaCl, 25mM HEPES, pH 6.8, and 0.1% β-mercaptoethanol for 30 minutes on ice. 
Crystallization followed the hanging drop protocol using 1 µL of the Dyn2-Nup159 pep2 
mixture and 1 µL of the 1 mL well solution: 0.3 M ammonium acetate, pH 5.5, 5% methyl 
pentanediol, and 35% polyethylene glycol 4000. Crystals grew at 20°C to 200 x 200 x 600 
µm over the course of a week. Crystals were transferred to fomblin oil (Sigma) for 
cryoprotection and flash frozen in liquid nitrogen. 
 Data Collection, Structure Determination, and Refinement - Dyn2-Nup159 pep2 
crystals were maintained at 100 K under a cryo-cooled nitrogen stream and diffraction data 
collected using a Rigaku Micromax 007HF x-ray generator (copper anode, 1.54 Å 
wavelength), Osmic mirrors and a Rigaku Saturn 944+ CCD in the UNC Macromolecular X-
Ray Crystallography Core Facility. 0.5° oscillations were collected over 160° from a single 
crystal. Data were indexed, integrated and scaled using HKL2000 (Otwinowski, 1997) (Table 
4-1). The structure was determined using the AutoMR molecular replacement program 
(PHENIX crystallographic suite (Adams, 2010)) and a modified 2PG1 (Williams, 2007) 
coordinate file in which a monomeric, apo Drosophila LC8 search model was used. The 
model was built using AutoBuild (PHENIX) (Adams, 2010) and refined iteratively through 
manual builds in Coot (Emsley, 2010) followed by refinement runs using phenix.refine 
(PHENIX) (Adams, 2010). Refinement statistics were monitored using a Free R, calculated 
using 10% of the data, randomly excluded from refinement (Brunger, 1992). The final model 
includes two Dyn2 molecules (chains A and C: residues 7-92), two Nup159 pep2 molecules 
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(chain B: residues 1117-1126; chain D: residues 1116-1126 with N1116 modeled as alanine) 
and 217 water molecules. 
 Size Exclusion Chromatography and Multi Angle Light Scattering - 100 µL of 200 
µM Dyn2 was injected onto a Wyatt WTC030S5 silicone size exclusion column (for elution 
of 5,000 – 1,250,000 Da proteins) in 50 mM NaCl, 25 mM HEPES, pH 6.8, 0.1% β-
mercaptoethanol, and 0.2 g/L sodium azide, and passed in tandem through a Wyatt DAWN 
HELEOS II light scattering instrument and a Wyatt Optilab rEX refractometer. The light 
scattering and refractive index data were used to calculate the weight-averaged molar mass 
(MW) and the mass fraction in each peak using the Wyatt Astra V software program (Wyatt 
Technology Corp.) (Wyatt, 1993). 
 Isothermal Microtitration Calorimetry - ITC experiments were carried out at 15°C in 
buffer B: 50 mM NaCl, 25 mM HEPES, pH 6.8, and 0.1% β-mercaptoethanol on a Microcal 
AutoITC200 (GE Healthcare). Peptides were exchanged into buffer B using G-25 Sephadex 
Quick Spin Columns (Roche). 17 x 2 µL injections of 1 mM pep2 or pep4 were 
automatically injected into 200 µL of 100 µM Dyn2. The resulting binding isotherms (Fig. 4-
6 A,B) were analyzed using the Origin 7.0 software package (OriginLab) and were fit to a 
one-site binding model. Experiments were conducted in triplicate and averaged to determine 
respective mean KD values with standard deviations as shown. 
 Protein Data Bank Accession Number - Coordinates for the Dyn2-Nup159 complex 
have been deposited in the Research Collaboratory for Structural Bioinformatics PDB under 
accession code 4DS1.     
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Results 
S. cerevisiae Dyn2 is a member of the conserved dynein light chain family - The dynein light 
chain, a component of the cytoplasmic dynein motor complex, is highly conserved from 
yeast to human (Fig. 4-1A). The dynein light chain is 90% identical across higher eukaryotes 
ranging from C. elegans to human, with significant identity extending to lower eukaryotes, as 
exemplified by the 50% identity between S. cerevisiae Dyn2 and D. melanogaster LC8. 
Across organisms, evidence points to the dynein light chain’s role as a factor that promotes 
substrate dimerization. While the dynein light chain is a component of the dynein 
microtubule motor complex, it is not exclusive to this complex. Recent work has shown that 
approximately 25% of the S. cerevisiae dynein light chain member, Dyn2, is associated with 
the nuclear pore complex. Dyn2 associates with the Nup82 cytoplasmic fibril complex, 
binding to pentavalent motifs arrayed in Nup159’s Dynein light chain Interaction Domain 
(DID) (Fig. 4-1 B-D) (Stelter, 2007). The Dyn2 binding motifs share a canonical QT motif 
with variable flanking components. Similar tandem binding sites have recently been mapped 
in the Dynein Intermediate Chain, Pac11, and shown to mediate Dyn2 interaction (Fig. 4-1 
C,D) (Stuchell-Brereton, 2011). To understand the molecular basis of the Dyn2-Nup159 
interaction, we cloned Dyn2 from S. cerevisiae (S288c) genomic DNA into the E. coli 
expression vector pGEX-6P-2, expressed and purified Dyn2 to homogeneity, removing the 
N-terminal GST tag. Nup159 peptides corresponding to the second and fourth Dyn2 DID 
binding sites (pep2 and pep4) were synthesized, purified by HPLC chromatography and 
verified by mass spectrometry analysis. Pep4 incorporated an N-terminal tyrosine to facilitate 
concentration determination while pep2 concentration was determined using its endogenous 
tyrosine. 
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Figure 4-1.    S. cerevisiae Dyn2 is a conserved dynein light chain involved in diverse 
macromolecular complexes including the nuclear pore complex and the cytoplasmic 
dynein motor complex.  
A. Sequence alignment of 12 dynein light chain family members ranging from S. cerevisiae 
to human. Residues aligned with 100% and 80% identity are colored green and yellow 
respectively. Amino acid numbers and secondary structure elements, based on the S. 
cerevisiae Dyn2 structure are shown above the alignment. Residues involved in Dyn2 
dimerization and Dyn2-Nup159 pep2 binding are indicated below the alignment by asterisks 
based on EMBL-EBI PDBe PISA (Protein Interfaces, Surface and Assemblies); black: 
Dyn2:Dyn2 chain A:C interactions; red: Dyn2:Nup159 pep2 chain A:D or chain C:B 
interactions; blue: Dyn2:Nup159 pep2 chain A:B or chain C:D interactions. Solvent 
accessible (SA) surface area for respective Dyn2 chain C residues is indicated below the 
alignment, calculated in the presence (black) and absence of the Nup159 pep2 chain D (gray) 
using the Accessible Surface Area Analysis tool in CCP4 (Collaborative, 1994). B. Cartoon 
diagram of the Nuclear Pore Complex illustrating the cytoplasmic localization of Nup159 
and the Nup82 complex to cytoplasmic fibrils. C. Domain architecture of known Dyn2 
binding proteins: Nup159 and Pac11. Nup159 is composed of an N-terminal β-propeller 
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domain involved in Dbp5 binding, central FG-rich repeats common to nucleoporins, a 
Dynein light chain interacting domain (DID) composed of five QT consensus motifs 
(residues 1103-1177) with Dyn2 binding activity, and a C-terminal region involved in 
Nup159 anchoring to the Nuclear Pore Complex (Stelter, 2007; Del Priore, 1997; Weirich, 
2004). Pac11, the yeast dynein intermediate chain, shares architectural similarities with 
Nup159, composed of an N-terminal coiled-coil domain, tandem Dyn2 QT binding motifs, 
and a C-terminal WD-40 repeat domain, predicted to be a β-propeller. D. Sequence 
alignment of the Dyn2 binding motifs from Nup159 and Pac11 highlighting the invariant QT 
motif. Nup159 pep2 secondary structure is indicated above the alignment. Nup159 pep2 
residues involved in Dyn2 binding are indicated by asterisks below the alignment, as is SA 
surface area, calculated in the presence (black) and absence of Dyn2 chains (gray). 
 
The Dyn2 homodimer forms two composite substrate binding sites using a central β-
sandwich and flanking α2-helices – To elucidate the structural determinants underlying the 
Dyn2-Nup159 interaction, we screened mixtures of Dyn2 and Nup159 pep2 and pep4 for co-
crystallization. We obtained crystals of the Dyn2-Nup159 pep2 (residues 1116-1126) 
complex using a 1:1.5 molar ratio of Dyn2 and Nup159 pep2 respectively. The crystals 
diffracted to 1.85 Å resolution and belonged to the space group P212121. We solved the 
structure by the molecular replacement method using a peptide-free monomeric chain 
derived from the Drosophila dynein light chain (2PG1) that showed 50% sequence identity 
with Dyn2 (Williams, 2007). Two Dyn2 chains occupy the asymmetric unit, homodimerized 
around a non-crystallographic two-fold axis. Clear electron density was evident for two 
Nup159 pep2 chains, each bound to the Dyn2 homodimer. The R and Rfree values for the 
Dyn2-Nup159 pep2 structure are 15.1% and 18.0% respectively. Crystallographic data and 
refinement statistics are presented in Table 4-1. Dyn2 homodimerizes across a composite 
central β-sandwich (Fig. 4-2A). Each β-sheet is composed of five β-strands arranged in an 
anti-parallel organization: β1-β4-β5-β2-β3’ in which the final β3’ strand is provided by the 
homodimeric mate. The prime interface between Dyn2 molecules is mediated by the anti-
parallel β2-β3’ strand interaction. Here, the β2-β3’ and β2’-β3 strand interactions 
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Figure 4-2.    Structure of the Dyn2-Nup159 pep2 complex shows a quaternary 
complex composed of a Dyn2 dimer, bound to two Nup159 pep2 peptides through 
parallel, composite β-sheets.  
A. Cartoon diagram of the Dyn2-Nup159 complex. Dyn2 chain A is shown in orange (α-
helices) and dark blue (β-strands), Dyn2 chain C is shown in beige (α-helices) and light blue 
(β-strands). The two-fold non-crystallographic symmetry operator that relates the Dyn2 and 
Nup159 chains in the asymmetric unit is indicated about the z-axis. Image at right shows the 
complex after a 90° rotation about the y-axis. B. The complex as shown in the two 
orientations in A, with Dyn2 chain A superimposed on the human dynein light chain, LC8 
(light green) bound to a PIN peptide (yellow) (pdb 1CMI) after a least squares fit with an 
RMSD of 0.6 Å over 87 aligned residues (Liang, 1999). Helices are shown in cylindrical 
format. Structural differences between Dyn2 and human LC8 are indicated by red arrows, 
and are dominated by loop regions as well as the bound peptides.  
 
encompass the non-crystallographic two-fold operator that relates each Dyn2 molecule. 
Flanking the central β-sandwich, each Dyn2 molecule contributes an α1 and α2 helix that 
bridge β1 and β2. The α1-α2 helix-turn-helix motifs symmetrically pack against the two β-
sheets that form the central β-sandwich. The Dyn2 homodimer symmetrically binds two 
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Nup159 peptides; the basis for the interaction is an extension of each β-sheet through an anti-
parallel strand that is stabilized through buttressing interactions with the neighboring α2-
helix.  
 Dyn2 architecture is homologous to other dynein light chain structures determined to 
date, with the highest structural homology to the human dynein light chain 8 (LC8) 
complexed with a peptide from the Protein Inhibitor of Neuronal Nitric Oxide Synthase 
(PIN) (pdb 1CMI), 0.6 Å Cα RMSD over 87 residues (47% identity, Fig. 4-2B), and ranged 
among dynein light chain structures to 2.3 Å Cα RMSD over 81 residues when compared to 
the dynein light chain structure 1YO3 from Plasmodium falciparum (37% identity) (Liang, 
1999; Vedadi, 2007). The main elements that show structural diversity between Dyn2 and the 
Drosophila LC8 structure (1CMI) are restricted to loop regions, specifically the α1-α2 loop, 
the β3-β4 loop and the β4-β5 loop. The core secondary structure elements of the domain 
show little plasticity. Diversity of allowable residues in the target peptide N-terminal to the 
canonical QT motif, in turn show structural diversity in the target β-strand backbone bound 
to the dynein light chain, as shown in the overlay of the Dyn2-Nup159 peptide structure with 
the human LC8-PIN peptide structure (Fig. 4-2B, Fig. S4-1). 
The Dyn2 homodimerization interface involves an extensive hydrophobic and 
electrostatic interface that buries approximately 940 Å2 of solvent accessible surface area on 
each Dyn2 molecule. Core β-strand-β-strand hydrogen bonding networks extend the anti-
parallel sheets across homodimeric mates (β2-β3’ and β2’-β3), augmented through additional 
backbone-side chain electrostatic interactions as well as van der Waals contacts between side 
chains (Fig. 4-3A). Helix α2’ packs against the β3 strand and buttresses the dimerization 
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Figure 4-3.    Dyn2 homodimerizes via an extensive network of van der Waals contacts 
and hydrogen bonds. 
A. Interaction matrix, showing the pseudo-symmetric bonding and contact networks formed 
between Dyn2 protomers A and C in the complex. Secondary structure elements 
corresponding to the residues of each protomer are indicated along the axes of the matrix. 
Backbone/backbone, backbone/side chain, side chain/side chain, and van der Waals 
interactions are indicated in blue, pink, red, and grey respectively and correlate with 
distances less than or equal to 3.5 Å (hydrogen bonds) and 4.5 Å (van der Waals contacts). 
Numbers in cells indicate the total number of hydrogen bonds (greater than one) between two 
residues. B. Diagram of key residues and structural elements involved in the Dyn2-Dyn2 
interface. The Dyn2 homodimer is shown as colored in Fig. 4-1. Specific Dyn2 residues 
mediating homodimerization are shown in stick format. Hydrogen bonds are indicated as 
dashed lines. The interface involves extensive antiparallel β-strand-β-strand interactions as 
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well as contributions from the α2 helices that flank the central β-sandwich. Inset shows the 
relative orientation of the complex. C. SEC-MALS analysis of Dyn2, injected at an initial 
concentration of 200 µM (green) in 100 µL. The Raleigh Ratio elution profile was 
normalized. Dyn2 predominantly forms a dimer in solution at pH 6.8, with additional, 
higher-order tetrameric and octameric species detected as well. The Dyn2 construct analyzed 
has a calculated monomeric molecular weight of 10,852 Da. 
 
interface through the use of charged side chains, primarily E38’ and K46’, that afford van der 
Waals contacts as well as hydrogen bonding to β3 residues N64 and T70 respectively (Fig. 4-
3 A,B). Overall, the homodimerization interface involves a pseudo-symmetric set of 
reciprocal interactions involving conserved residues (Figs. 4-1A, 4-3A).  
 Dyn2 exists as a multimer in solution – While the crystal structure of the Dyn2-
Nup159 pep2 complex showed Dyn2 in a homodimeric state, we wanted to determine 
whether this dimeric form existed in solution in the absence of bound peptide. To determine 
Dyn2’s oligomeric state, we utilized size exclusion chromatography coupled with multi-
angle light scattering (SEC-MALS). We analyzed the elution and mass profiles of purified 
Dyn2 injected at an initial concentration of 200 µM. The Dyn2 elution profile contained three 
main peaks with masses respectively calculated at 25.8 kDa, 50.5 kDa and 87.8 kDa. On 
average, 87% of the eluted mass fraction was in the 25.8 kDa peak (Fig. 4-3C). The 
theoretical calculated molecular mass of our Dyn2 construct is 10,852 Da. Thus, under the 
conditions analyzed, peptide-free Dyn2 was found primarily as a homodimer with the 
remaining population in higher-order oligomeric states.  
 The Dyn2 homodimer binds parallel Nup159 peptides using a conserved composite 
binding site – Nup159 contains a pentameric array of Dyn2 binding sites (Stelter, 2007). In 
the structure we present here, the Dyn2 homodimer is complexed with two Nup159 peptides  
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Figure 4-4.    Dyn2 binds substrates through a highly conserved, positively charged 
composite groove formed by Dyn2 dimerization.  
A. Conservation, as highlighted in Fig. 4-1A (green: 100% identity, yellow: 80% identity, as 
determined across twelve diverse species), mapped on the Dyn2 dimer shown in surface 
representation. Nup159 pep2 is shown in stick format in purple, inserted in the highly 
conserved interdimer groove. The highly conserved QT substrate motif (green sticks) is 
located C-terminal to the Nup159 pep2 β-strand. Conservation however, is equally 
distributed across the Dyn2 substrate-binding region. Inset shows the relative orientation of 
the complex in cartoon format colored as in Fig. 4-2A. B. Electrostatic surface calculated 
using APBS to generate solvent accessible surface potentials that are shown in kBT/e, colored 
according to the key shown (Baker, 2001). Nup159 pep2 is shown in purple stick format with 
specific Dyn2 residues involved in hydrogen bond contacts labeled. The conserved QT motif 
is shown in green stick format. Dyn2:Nup159 pep2 interactions include Y68:E1119, 
E38’:Q1123 and K12:D1125. The complex is oriented as in A. 
 
corresponding to the second Dyn2 binding site in the Nup159 DID. The Nup159 peptide 
binds in a conserved pocket formed at the Dyn2 homodimer interface, consisting of both 
hydrophobic and charged residues (Fig. 4-4B). Nup159 pep2 (chain B) buries 911 Å2 of 
solvent accessible surface area while each of the Dyn2 molecules bury 512 and 129 Å2, for a 
collective 641 Å2 of solvent accessible surface area buried at a single Nup159 pep2 binding 
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site. 16 of the 25 Dyn2 residues involved in Nup159 peptide binding are 100% invariant 
across the twelve species shown in Fig 4-1A, and 22 of the 25 are at least 80% invariant 
across these species (Fig. 4-4A). In Nup159, the glutamine (Q1123) and threonine (T1124) 
that constitute signature dynein light chain binding determinants, bind to the periphery of the 
peptide binding cleft in an area of high dynein light chain conservation. Analysis of the Dyn2 
electrostatic surface shows that the peptide binding cleft is composed of mixed charges near 
the peptide N-terminal region while positive charges dominate the electrostatic potential at 
the peptide’s C-terminal region. Key salt bridges in the complex include interactions between 
the invariant Dyn2 K12 and Nup159 D1125 as well as Dyn2 E38’ and Nup159 Q1123. The 
Nup159 peptides form a β-strand interaction, extending the central β-sheets formed by Dyn2 
homodimerization. The Nup159 β-strand runs anti-parallel to the Dyn2 β3 strand and extends 
across seven residues, terminating at the glutamine, Q1123, that composes the QT motif (Fig. 
4-4, 4-5). The Nup159 Q1123 side chain forms a network of hydrogen bonds with the start of 
the neighboring Dyn2 α2’ helix; capping the end through interactions with the R39’ 
backbone amine as well as one of the E38’ side chain  arboxyl oxygens. In addition, the 
Q1123 side chain forms a hydrogen bond with the F65 backbone amine on β3. Q1123’s 
backbone is stabilized through a hydrogen bond to Dyn2’s Y78 hydroxyl group (Fig. 4-5 A-
C). T1124 from the Nup159 QT motif forms extensive contacts with Dyn2 F65, engaging the 
F65 backbone carbonyl and amine through hydrogen bonds from its own backbone amine 
and side chain hydroxyl group. The T1124 side chain γC also forms van der Waals contacts 
with the F65 benzene ring. Preceding the QT motif, the N-terminal six Nup159 residues 
primarily use an anti-parallel β-strand-β-strand hydrogen bond network as well as van der 
Waals contacts to bind the conserved Dyn2 groove, indicative of the highly variable 
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Figure 4-5.    The Dyn2:Nup159 pep2 interaction is mediated by an extensive 
interaction network that recognizes ten contiguous Nup159 residues, dually conferring 
specificity and substrate plasticity.  
A. and B. Close up of residues involved in the Dyn2:Nup159 pep2 interaction. Secondary 
structure elements are shown as in Fig. 4-2A, with specific residues that mediate the 
Dyn2:Nup159 pep2 interaction shown in stick format and their corresponding hydrogen 
bonding network shown with dashed lines. C. Interaction matrix, showing the contact 
networks formed between Dyn2 protomers A and C with Nup159. Secondary structure 
elements and protomer designation are indicated along matrix axes. Backbone/backbone, 
backbone/side chain, side chain/side chain, and van der Waals interactions are indicated in 
blue, pink, red and gray respectively and correlate with distances less than or equal to 3.5 Å 
(hydrogen bonds) and 4.5 Å (van der Waals contacts).  
 
composition accepted in dynein light chain targets. Overall, the Nup159 pep2:Dyn2 interface 
is mediated by extensive hydrogen bonding and van der Waals contacts involving ten 
residues in the Nup159 peptide. All Nup159 residues modeled contact one Dyn2 protomer 
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and six of these ten residues make additional contacts with the Dyn2’ homodimeric mate, 
indicating that high-affinity Dyn2-substrate recognition is mediated via Dyn2 dimerization. 
The Nup159 pep2:Dyn2 interface buries 1565 Å2 of solvent accessible surface area at each 
binding site. The two Nup159 peptides bound to the Dyn2 homodimer run parallel to each 
other, related by a two-fold symmetry axis, with their mid points separated by approximately 
20 Å.  
  
Figure 4-6.    The Dyn2 interaction with Nup159 pep2 and pep4 occur in a 1:1 
stoichiometry, and exhibit similar affinities but differ in their thermal binding modes.  
A. 17 x 2 µL of 1 mM Nup159 pep2 was injected into 200 µL of 100 µM Dyn2. The 
thermogram (upper panel) displays µcal/sec over the injection period (min). B. 17 x 2 µL of 1 
mM Nup159 pep4 was injected into 200 µL of 100 µM Dyn2. Dyn2 binding to Nup159 pep2 
(A) displayed an endothermic binding isotherm, while Dyn2 binding to Nup159 pep4 (B) 
showed exothermic binding. Thermograms (upper panels) were integrated and the resulting 
isotherm was fit to a one-site binding model (lower panels) through iterative fitting. KD 
values presented (inset, lower panel) are the average of three independent experiments: 
Dyn2-Nup159 pep2: KD = 17.9 ± 3.8 µM, ∆H = 2500 cal/mol, ∆S = 31 cal/mol/deg, N = 0.33 
sites; Dyn2-Nup159 pep4: KD = 13.1 ± 1.6 µM, ∆H = -4000 cal/mol, ∆S = 8.6 cal/mol/deg, N 
= 0.39 sites. 
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 Nup159 DID sites two and four respectively bind Dyn2 with 17.9 and 13.1 µM 
affinity, using differential thermal binding modes – To determine the affinities between Dyn2 
and the five Nup159 Dyn2 binding sites in the DID, we synthesized the respective peptides 
and performed isothermal titration calorimetry, titrating peptides into the calorimeter cell 
containing Dyn2. Each Nup159 peptide binding experiment was performed in triplicate and 
the fitted values were averaged. Each individual binding experiment was best fit to a one-site 
model (using the Dyn2 monomer concentration) (Wyatt, 1993). Pep2 showed an endothermic 
isotherm (Fig. 4-6A) while pep4 showed an exothermic isotherm (Fig. 4-6B). The 
experimentally determined affinities between Dyn2 and Nup159 pep2 and pep4 are shown in 
Fig. 4-6 and have KDs equal to 17.9 and 13.1 µM respectively. Pep3 did not show sufficient 
signal to noise and was not soluble at the concentrations needed to determine binding 
accurately. Pep1 and Pep5 are highly hydrophobic and once solubilized, failed to show 
binding to Dyn2 as determined using isothermal titration calorimetry (data not shown). This 
may be due to the weaker binding affinities for these peptides as was qualitatively shown in 
the aforementioned PepScan assay (Stelter, 2007), or due to a folded/aggregated state that 
precluded Dyn2 from binding. 
 Translational arrangement of the Dyn2 homodimer facilitates contiguous binding to 
arrayed QT motifs – The arrangement of delineated QT motifs in Nup159 are nearly 
contiguous, separated by one or two amino acids except for a tentative QT region linking 
sites two and three that showed no Dyn2 binding activity in the previously mentioned 
PepScan assay (Stelter, 2007). In the same investigation, electron microscopy of the 
Dyn2:Nup159 DID complex showed five densities arranged like beads on a string, leading  
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Figure 4-7.    Crystallographic contacts array Dyn2 dimers linearly in an arrangement 
that affords polarized binding to arrayed Dyn2 binding motifs.  
Dyn2-Nup159 crystallographic symmetry mates shown in cartoon representation, colored as 
in Fig. 4-2A. Dyn2 interdimer interactions coupled with parallel, arrayed binding motifs on 
Nup159 likely promote linear, cooperative binding activity between Dyn2 dimers and 
Nup159. 
 
the authors to propose a model in which five Dyn2 dimers bound parallel Nup159 DID arrays 
(Stelter, 2007). Stelter et al. modeled the bound Dyn2 dimers in a translational array. In the 
P212121 lattice presented here, we note a translational arrangement of Dyn2 dimers in the 
crystal lattice, that supports the Stelter et al. Dyn2:Nup159 complex model. As shown in Fig. 
4-7, Dyn2:Nup159 pep2 complexes are translationally arranged in the crystal, with a 34 Å 
translational component approximately collinear to the Nup159 peptide, effectively placing 
the C-terminus of one Nup159 peptide proximal to the N-terminus of the neighboring 
Nup159 peptide. Five Dyn2 dimers in this crystal lattice span 170 Å, on par with the 20 nm 
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filaments observed by Stelter et al. in electron micrographs of the Dyn2:Nup159 DID 
complex. 
 
Discussion 
 The dynein light chain, while a component of the cytoplasmic dynein motor complex, 
is promiscuous and has been identified as a component in numerous, diverse complexes. A 
universal role postulated for the dynein light chain is to serve as a dimerization machine. In 
S. cerevisiae, 25% of the Dyn2 cytoplasmic pool is found associated with the nuclear pore 
complex (Stelter, 2007). Nup159, a component of the Nup82 complex of the cytoplasmic 
fibrils, was identified as a Dyn2 binding partner that promotes stable association of the 
Nup82 complex with the NPC (Stelter, 2007). Nup159’s pentameric array of Dyn2 binding 
sites link the N-terminal FG repeat region with the C-terminal NPC anchor region (Yoshida, 
2011).  
 Our analysis of Dyn2 homodimer binding to individual Nup159 peptides showed 
similar affinities for pep2 and pep4, at 17.9 µM and 13.1 µM respectively, while binding for 
pep1, pep3, and pep5 could not be experimentally determined based on properties of the 
individual peptides as synthesized. Binding curves fit best to a one-site binding model and 
are comparable to LC8 binding to peptides of similar size: DYNLL1 binds a seven amino 
acid peptide from Bmf with a KD of 1.1 µM and similarly sized nNOS peptide with a KD of 
7.0 µM (Radnai, 2010). The affinities determined between Dyn2 and the Nup159 peptides do 
not take into account potential cooperativity between arrayed Dyn2 homodimers based on 
interactions we observed in translational symmetry mates in the Dyn2:Nup159 crystal. The 
affinities and differential thermal binding modes determined for Nup159 pep2 and pep4 
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reflects plasticity in the Dyn2 binding pocket. The Dyn2 binding site does not have many 
steric occlusions, and can thereby accommodate sequence diversity as observed with the LC8 
family (Fan, 2001; Radnai, 2010; Rapali, 2011). The Dyn2:Nup159 crystal structure shows 
that extensive backbone/backbone interactions mediate the anti-parallel β-sheet extension. 
This backbone-based interaction affords tight binding while simultaneously enabling 
diversity in the side chains that flank the core, conserved QT binding motif. The QT motif is 
present in most Dyn2/LC8 binding peptides characterized to date and constitutes the C-
terminal flank of the target peptide’s β-strand. The QT motif contributes a network of 
hydrogen bonds and van der Waals contacts with the dynein light chain’s conserved grove, 
directly contacting residues from each subunit of the homodimer. The amino acid diversity 
flanking the QT motif likely underlies the differential affinities and thermal binding modes 
observed across dynein light chain targets. Pep4 exhibited exothermic binding, indicative of a 
strong enthalpic, electrostatically-driven interaction, while pep2 exhibited endothermic 
binding, indicative of a hydrophobic, entropically-driven interaction. Pep2 and pep4 each 
have electrostatic and hydrophobic residues. A key hydrophobic determinant that may 
underlie the endothermic binding observed with Nup159 pep2, is the tyrosine residue at 
position 1117, 6 residues upstream of the QT motif (i.e. Q-6; see Fig. 4-1D). The 
corresponding residue in Nup159 pep4 is an alanine. The Nup159 pep2 Q-6 tyrosine makes 
numerous van der Waals contacts with the Dyn2 homodimer (Fig. 4-5C). Peptide-specific 
exothermic and endothermic binding has been observed with Dyn2 homologs from other 
species and highlights the sequence diversity within target sites that dynein light chains are 
capable of accommodating (Benison, 2008; Radnai, 2010; Rapali, 2011; Hodi, 2006; 
Wagner, 2006; Nyarko, 2011). 
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 Our work represents the first biophysical and structural characterization of the yeast 
dynein light chain, Dyn2. At physiological conditions, Dyn2 exists predominantly in the 
homodimeric state. As a homodimer, Dyn2 is positioned to interact with target sites and 
induce and stabilize parallel dimerization in these target proteins. Dimerization machines can 
crosslink targets, homo or heterodimerize targets, serve to architecturally extend a target, as 
well as promote a target’s avidity for binding partners. The Dyn2:Nup159 structure creates a 
foundation for understanding Dyn2’s role in the NPC as a dimerization machine that can 
scaffold Nup159 and extend the protein at least 170 Å (5 x 34 Å). Our structural and 
biophysical investigations of the Dyn2:Nup159 interaction have additional implications for 
Dyn2’s mode of interaction and function with the dynein intermediate chain, Pac11, its 
potential role in promoting Pac11 dimerization and aiding in the recruitment of the dynein 
activation complex, dynactin (Stuchell-Brereton, 2011). 
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Supplemental Figure 4-1.    The dynein light chain is highly plastic with regard to 
target peptide binding.  
A. Superpositioning of four dynein light chain target peptides solved to date. Peptides are 
modeled in the presence of Dyn2 after a least squares fit of each structure’s respective dynein 
light chain (not shown). Dyn2 is shown in gray surface representation. Peptides are shown in 
stick format. Nup159 peptide two is shown in purple. The Swallow (Swa) peptide is shown 
in blue (pdb 3E2B), the dynein intermediate chain (DIC) is shown in orange (pdb 2PG1) and 
the PIN peptide (1CMI) is shown in yellow (Williams, 2007; Benison, 2008; Liang, 1999). 
Inset shows the orientation of Dyn2 and the peptides in cartoon format. B. The peptides 
shown in A are presented in stick format and surface representation to highlight unique and 
differential features. The N-terminal region of the peptides show the greatest diversity. The 
conserved QT motif is towards the C-terminal region and is colored in green stick format. C. 
Sequence alignment of the peptides shown in B. The QT motif is highlighted in green, 
showing divergence in the PIN peptide: QV. 
 
 
 
 
 
CHAPTER 5 
DISCUSSION AND FUTURE WORK 
 
Discussion 
The importance of studying the dynein light chain, Dyn2/Lc8 
The dynein light chain, Dyn2/Lc8 has, until recently been discussed in light of its 
function at the dynein complex for which it was named. More recent publications illuminate 
Dyn2/Lc8’s ability to interact with a number of cellular targets that function in very 
specialized and highly regulated roles (McCauley, 2007; Lightcap, 2008; Espindola, 2000; 
Benison, 2007). Here we explore Dyn2/Lc8’s interaction at the dynein complex, as well as 
two of Dyn2/Lc8’s additional roles in dimerizing Nup159 at the nuclear pore complex, and 
dimerizing Ana2 in the early stages of centriole duplication. 
The phenotype of Lc8/Dyn2 is not lethal in any of the model organisms surveyed to 
date, however, the severity of the deletion phenotypes for Lc8/Dyn2’s binding partners can 
be cataclysmic and result in an inviable cell. When Lc8 is mutated to a null protein there can 
be slight defects in spindle orientation, which can result in a small percentage of cells 
dividing incorrectly or delayed in anaphase (Wang, 2011; Stuchell-Brereton, 2011). In the 
case of Dyn2’s interaction at the nuclear pore protein, Nup159, the phenotype for dyn2∆ is a 
viable cell that may have slightly decreased fitness compared to WT (Breslow, 2008), but 
does not compare to the inviable cell in the null mutation of Nup159 (Stelter, 2007). A 
similar cellular defect is found when Lc8’s binding partner, Ana2, is overexpressed in 
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Drosophila cells there is widespread over-proliferation of centrioles that results in genomic 
instability and can have the consequence of nuclear fallout (Stevens, 2010). It is the fact that 
Dyn2/Lc8 binds to these important cellular targets that makes Dyn2/Lc8 of great interest in 
optimizing target protein function, or as a point of regulation in the cell. Many of our 
outstanding questions involve how Dyn2/Lc8 modulates a protein’s behavior through its 
function as a scaffolding protein. 
In this body of work we show that Dyn2 forms a stable homodimer in solution, just as 
its higher eukaryote counterpart, Lc8, which acts as a scaffolding protein to encourage or 
stabilize dimerization of target proteins as a “dimerization machine”. Dyn2/Lc8 is capable of 
binding to multiple cellular target proteins through a conserved QT sequence motif at the 
dynein intermediate chain, the centriole duplication factor, Ana2, and at the nuclear pore 
complex with Nup159. Here we show the first published structure of the S. cerevisiae, Dyn2, 
for which there is only 50% sequence identity between Dyn2 and the Drosophila, Lc8 
(Romes, 2012). We show that there is structural commonality between Dyn2 and Lc8 that 
illustrates their ability to both bind the conserved QT motif in spite of their sequence identity 
difference. Dyn2’s promiscuity in binding partners is highlighted by its flexibility to bind 
peptides with varying sequence outside of the QT motif and with different thermodynamic 
binding modes. 
Dyn2/Lc8 is expressed ubiquitously throughout the cell, and has taken up a 
promiscuous role in binding many different protein targets with more than one type of 
thermodynamic binding mode. Dyn2/Lc8’s deletion mutant or null mutation phenotype 
indicates that it is not an essential protein in the cellular contexts where it is found, but we 
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hypothesize that it acts as a point of regulation when it is phosphorylated and increases its 
binding partner’s efficiency for binding other target proteins through homodimerization. 
Dyn2 interacts at the dynein complex to homodimerize the intermediate chain, Pac11 
The dynein holoenzyme is involved in many different, very important cellular contexts 
that determine cell viability in higher eukaryotes, and the efficiency of spindle movement 
during S. cerevisiae’s cell division. The dynein intermediate chain, Pac11 has been shown to 
bind to the dimerization domain of the dynein heavy chain to act as a scaffolding protein that 
binds many dynein-associating factors. The dynein light chain is an associating factor that 
binds directly to Pac11 to act as a scaffold for Pac11 to dimerize. There are two putative 
Dyn2 binding sites on Pac11 that contain conserved QT binding motifs, and we confirm that 
the second site binds to a Dyn2 homodimer with an extensive hydrogen bonding network and 
a strong affinity. We obtained a 1.90 Å crystal structure of the 2:2 Dyn2-Pac11 pep2 
complex, which highlights Dyn2’s ability to mediate dimerization of Pac11. The Q82 and 
T83 of Pac11 pep2 provide five hydrogen bonds for the extensive hydrogen bonding network 
and feature their prominence as the Dyn2 binding recognition motif. We found that Dyn2 
binds to the Pac11 pep2 with a 620 nM affinity, which is the strongest Dyn2 interaction 
characterized to date. Through our exploration of the Dyn2-Pac11 pep2 complex we 
characterized distinct mutational sites that separately abrogate Dyn2 dimerization and Dyn2 
binding to the Pac11 pep2. A single point mutation of H58K in the core of the dimerization 
interface acted like a switch to ablate Dyn2’s ability to form a stable dimer in solution, as 
was shown for the corresponding H55 in Lc8 (Nyarko, 2005). Although the distance between 
the H58 imidazole rings is 5.4 Å, it appears that protonation at low pH or disturbance of this 
particular residue through mutation is enough to affect the delicate balance of dimerization. 
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Romes, 2012 details the extensive hydrogen bonding network and van der Waals forces 
involved in dimerization of Dyn2 that contribute to dimerization affinity. The dimerization 
affinity was measured for Lc8 to be 12 µM and showed that the Lc8 monomer β3 strand 
gained order upon dimerization and upon binding to a target protein/peptide (Nyarko, 2005).  
Consistent with previous Lc8 findings, disturbance of homodimerization consequently 
abrogated Dyn2’s ability to bind to the Pac11 pep2, which shows that homodimerization of 
Dyn2 is necessary for binding to the Pac11 pep2. Our work and others’ work demonstrates 
the necessity of Dyn2/Lc8 dimerization for forming the peptide-binding cleft to build the 
extensive hydrogen-bonding network (Romes, 2012; Wang, 2003; Benison, 2009). We saw 
in the case of Dyn2 binding Nup159 pep2 that key residues (E38 and R39) in the second 
Dyn2 monomer contributed hydrogen bonds along with a number of van der Waals 
interactions throughout the second α-helix which all encourage stabilized binding. 
We designed a double mutation in the peptide-binding pocket at F76K/Y78E to set up a 
charge repulsion with the intention of ablating peptide binding but maintaining the Dyn2 
dimerization interface. We confirmed that the F76K/Y78E mutations allowed Dyn2 to 
dimerize in solution, but abolished the ability to bind to the Pac11 pep2. We hypothesize that 
this Dyn2 double mutant may be utilized to eliminate Dyn2 binding interactions in target 
proteins with a (+)xxQT(-) motif (where + indicates a K/R/H residue and – indicates a D/E 
residue). 
In our binding assays we were unable to show that Dyn2 binds to previously determined 
binding motifs in Nup159 pep1, pep3, and pep5 as well as Pac11 pep1 due to the peptides’ 
insoluble nature and inherent hydrophobicity. We hypothesize that Dyn2 would bind at these 
locations in the context of the full length Nup159 or Pac11. The first Pac11 pep1 binding site 
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aligns with the TcTex binding site for higher eukaryotes and begs the question why higher 
eukaryotes evolved the ability to bind to a different dynein light chain at this site. Although 
we were unable to answer whether there are intrinsic differences in Dyn2 binding to the two 
Pac11 binding sites, we surmise that since there are sequence differences between these two 
sites, Dyn2 is able to overcome these possible thermodynamic or steric differences through 
its flexible binding pocket as it binds promiscuously to other target proteins throughout the 
cell. 
Lc8 homodimerizes the essential centriole duplication protein, Ana2 
The process of centriole duplication is a highly regulated and conserved mechanism for 
duplicating the machinery, which controls many functions of proper DNA segregation during 
cellular division (Nigg, 2011). Centrioles duplicate exactly once every cell cycle to yield a 
pair composed of one mother centriole and a maturing orthogonal centriole (Kitagawa, 
2011). In the initiation phase of duplication a few necessary proteins, including Sas6 and its 
binding partner, Ana2, form a single procentriole (Carvalho-Santos, 2010). Overexpression 
of Ana2 results in multiple procentrioles and can lead to genomic instability (Arquint, 2012). 
Ana2 and its binding partner, Lc8 are both important for the spindle orientation in 
asymmetric cell division (Wang, 2011). Previously Lc8 was not known to have a significant 
phenotype (Zhang, 2009), so this is the first example of Lc8’s independent and Ana2-
dependent function in asymmetric cell division. The Lc8 binding sites on Ana2 was 
hypothesized to be located within a central domain, which contains a coiled-coil (Wang, 
2011), but not much was known about how this interaction might abrogate their function in 
orienting the spindle. 
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We have solved the 1.83 Å crystal structure of the Lc8 homodimer in complex with two 
bound Ana2 pep1s. This structure demonstrates that Lc8 binds Ana2 pep1 in the same 
peptide-binding pocket where the conserved QT motif aligns and makes similar binding 
contacts as other Lc8-peptide binding interactions. We are continuing to refine the Lc8-Ana2 
pep1 crystal structure so that we may dissect the binding interactions that make this a tight 
binding interaction for Lc8. We have also obtained crystals for the Lc8-Ana2 pep2 in 
different crystallization conditions and with a completely dissimilar morphology. We were 
not able to obtain adequate diffraction of these crystals so we will continue to optimize and 
refine the conditions so that we may determine the differences between Lc8 binding a 
canonical QT motif versus a non-canonical QC motif from the second Ana2 binding site. 
Here we show that Lc8 binds to Ana2 exothermically through two binding sites, one of 
which contains a canonical QT binding motif (site 1), and the other a non-canonical QC 
motif (site 2). We demonstrate through ITC that Lc8 binds the canonical binding motif with 
the higher affinity of 0.54 µM, and the non-canonical binding motif with 12.7 µM affinity. 
Both of these affinities are within the typical range of Lc8 binding affinities, however it is 
unusual that Lc8 is able to bind to two different sites on the same protein with affinities on 
either end of Lc8’s usual binding range. The second Lc8 binding site is just C-terminal to 
Ana2’s central coiled-coil domain, and both binding sites are located within a region of Ana2 
that was shown to be important for Ana2 localization to the centrioles (Wang, 2011). 
Dyn2 interacts with five consecutive Nup159 binding sites within the nuclear pore complex 
cytoplasmic fibril 
The nuclear pore is a structure that gates all asymmetric traffic into and out of the nucleus 
(Fahrenkrog, 1998). The pore is especially significant in controlling the export of mRNA out 
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of the nucleus and into the cytoplasm for translation (Cole, 2006). On the cytoplasmic side of 
the nuclear pore there are structures called the cytoplasmic fibrils, which act as the last 
checkpoint in gating, and may assist in pulling through the pore larger transiting complexes 
(Zhao, 2002). Previous work has shown that Dyn2 interacts with one of the essential 
cytoplasmic fibril proteins, Nup159 in a domain near the C-terminus that helps to anchor 
Nup159 into the nuclear pore (Stelter, 2007; Stuchell-Brereton, 2011). Here we are interested 
in the biophysical role that Dyn2 plays in functionally dimerizing Nup159 through binding 
and structural assays. 
We demonstrate the first published structure of Dyn2 in complex with a Nup159 pep that 
shows the importance of the Dyn2 QT binding motif. We parse out the network of hydrogen 
bonding interactions between Dyn2 and Nup159 pep2, as well as the importance of salt 
bridges for recognition and additional stability in this binding reaction. We see that although 
the Dyn2 binding site is not a charged environment, there are charged residues on either end 
of the binding pocket that form electrostatic interactions with oppositely charged residues on 
the Nup159 peptide. The five sequential Dyn2 binding motifs on Nup159 contain very 
different sequence, but highlight Dyn2’s malleable binding requirements that support binding 
driven by binding affinity and not induced fit or sterics. 
We show that Dyn2 can bind two Nup159 peptides in solution with similar affinities but 
different binding modes through ITC. Dyn2 binds to Nup159 pep2 with 17.9 µM affinity and 
an endothermic profile which suggests a rearrangement of structural waters and the 
composite consolidation of hydrophobic residues within the binding interaction. Nup159 
pep4 binds to Dyn2 with a similar 13.1 µM affinity, but in an exothermic binding profile 
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which is common for many binding interactions. This is the first example of Dyn2 or Lc8 
binding along the same protein with two different binding modes. 
We hypothesize with the support of these data that Dyn2 binds the consecutive Nup159 
binding sites with cooperativity to increase the avidity of the Dyn2-Nup159 interaction. This 
zippering affect of cooperativity allows Dyn2 to have a lower binding affinity than has been 
seen for most Dyn2/Lc8 binding interactions, but still mediate a productive Nup159 dimer. 
We also envision that Nup159 dimerizing through Dyn2 allows it to have less dedicated 
peptide sequence than would be required for a full coiled-coil dimerization so that Nup159 
can utilize that sequence to further extend into the cytoplasm. 
Dyn2 binds target proteins with a large number of hydrogen bonds that are highly conserved 
within the Nup159 and Pac11 networks.  
Our studies on Dyn2 and Lc8 have uncovered the mode with which the Dyn2/Lc8 
homodimer uses to recognize and bind a variety of target proteins. Here we showed that the 
Dyn2 peptide-binding pocket sequence is well conserved among an alignment of 12 species 
(Fig. 4-4A). We find that the Dyn2 binding pocket does not contain charged residues except 
two peripheral lysines that only make salt bridge contacts with specific binding sequences 
(Fig. 4-4B). We therefore conclude that Dyn2 does not bind proteins through charge-charge 
interaction, but instead utilizes an extensive network of hydrogen bonds and van der Waals 
contacts (Fig. 4-5C; Fig. 2-3B). We also found that a number of different types of hydrogen 
bond contacts are conserved between the Nup159 pep2 and Pac11 pep2 binding interfaces 
with Dyn2 (Fig. 2-3C). We hypothesize that the extensive hydrogen-bonding network and 
van der Waals forces contribute to the µM binding affinities that are observed between Dyn2 
and the target peptides we have measured here. 
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Future Work 
We would like to further investigate the purpose of Dyn2/Lc8 as a dimerization machine 
in these various cellular contexts. Since we see Dyn2/Lc8 as a ubiquitous protein that is able 
to promiscuously bind various target proteins through malleable binding requirements, we 
anticipate that further examples of Dyn2/Lc8 dimerizing important protein targets will 
surface. We recognize that although Dyn2/Lc8 are dynein light chains in name it is probable 
that this was not their original functional location. Some species of plants and algae contain 
only the Lc8 light chain, but do not contain the dynein motor for intracellular transport. We 
are curious how Dyn2/Lc8 evolved the ability to bind to new targets throughout the cell, and 
why many of these targets exhibit strong null phenotypes, which suggests the target proteins’ 
importance in their various cellular contexts.  
Much of our future work revolves around determining the importance of Lc8/Dyn2’s 
dimerization of target proteins. We are currently collaborating with Arne Gennerich to 
determine whether Dyn2’s ability to dimerize the dynein intermediate chain, Pac11 
modulates processivity or velocity of dynein along microtubule tracks. The point mutations 
we developed from biophysical and structural studies will hopefully allow the Gennerich lab 
to parse out the importance of the Dyn2-Pac11 dimerization interaction for dynein.  
Since Lc8 and Dyn2 are so ubiquitously expressed and utilized throughout the cell in 
a number of different contexts, we would like to investigate how Lc8/Dyn2 is regulated. We 
believe that Lc8/Dyn2-mediated dimerization is the perfect point of regulation. Song et al. 
have shown that Lc8 is phosphorylated on Ser88 (Dyn2 contains a Thr91 that aligns with 
Ser88) to cause dissociation of the dimer, which in turn ablates Lc8’s ability to bind target 
proteins (Song, 2008; Benison, 2009). We aim to determine whether Dyn2 and Lc8 are 
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phosphorylated at the dynein complex, at the nuclear pore, and at centriole duplication. We 
will utilize the phosphomimetic mutation used in Benison et al. to assay the importance of 
Dyn2/Lc8 phosphorylation in dimerization (Benison, 2009).  
Additionally, we aim to determine whether Lc8 interacts with Ana2 at the site of 
centriole duplication to modify centriole number in dividing Drosophila S2 cells by ablating 
the Lc8 binding sites on Ana2. Studies to date have not shown what role Lc8-mediated 
dimerization plays, and whether the Ana2 coiled-coil is sufficient for dimerization. We 
propose a simple SEC-MALS Ana2 experiment to determine the oligomer state of Ana2 in 
the absence of Lc8. This experiment would illuminate whether full length Ana2 is capable of 
dimerizing without Lc8 mediation. We also aim to look at the dimerization state of an Ana2 
construct that contains the two Lc8 binding sites and the putative coiled-coil, to determine 
whether this is the minimal domain for dimerization. Additionally we are still refining 
structural data of the Lc8-Ana2 pep1 co-crystallization structure, and we aim to solve the 
structure of the Lc8-Ana2 pep2 complex. We hypothesize that the Lc8-Ana2 pep2 complex 
may explain how Lc8 is capable of binding such different sequences, even when the 
canonical QT motif is not maintained. 
With the biophysical information we have gathered on Lc8/Dyn2’s mechanism for 
binding target peptides in the dynein complex, at centriole duplication, and in the nuclear 
pore, we have developed Dyn2 mutational tools that may help us determine whether 
dimerization is necessary or just helps to optimize function for Pac11, Ana2, and Nup159. If 
dimerization of these and other target proteins increases their avidity for other protein-protein 
interactions, then Dyn2/Lc8-mediated dimerization affords optimized binding, much in the 
same way that it is easier to catch a ball with two hands than with a single hand. 
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